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ABSTRACT
The adenovirus type 2 origin of DNA replication is located within 
the terminal 51 bp of the viral genome and contains three recognisable 
domains: the minimal origin or 'core' and binding sites for the cellular 
transcription factors Nuclear Factor I and Nuclear Factor HI. Initiation 
of Ad2 DNA replication is preceded by the assembly of a nucleoprotein 
complex at the viral origin of DNA replication. Recombinant 
baculoviruses were previously constructed which express full-length 
Nuclear Factor I (NFIf l ) or its DNA binding domain (NFId b d ) for use 
in experiments. DNase I footprinting experiments were carried out to 
examine the cooperative interaction between NFI and DBP. DBP can 
increase the binding affinity of both N H fl  and NFId b d  for their 
recognition site in the Ad2 origin of DNA replication. Mini-columns 
containing NFId b d  covalently linked to CNBr-activated Sepharose were 
used to demonstrate that the adenovirus DNA polymerase (pol) interacts 
with NFI on its own and as part of the precursor terminal protein (pTP)- 
pol heterodimer.
Immunofluorescence experiments have shown that NFI is 
specifically targeted to sites of ongoing viral DNA replication in Ad2 
infected cells but not in Ad4 infected cells. This localisation of NFI to 
discrete subnuclear sites reflects the requirement for NFI for efficient 
initiation of Ad2 DNA replication. The viral transcriptional activator 
E la  is also localised to discrete subnuclear sites which are very different 
from those of DBP and are cell cycle dependant. Antibodies to RNA 
polymerase II show that although its cellular distribution is also cell 
cycle dependant it is different from both DBP and Ela. When the sites 
of active transcription were labelled in Ad2 infected cells they were 
shown to be distinct from both the E la and RNA polymerase II nuclear 
distribution.
INTRODUCTION
The main subject of this thesis is to investigate the formation and 
cellular location of a nucleoprotein complex at the Adenovirus Type 2 
(Ad2) origin of DNA replication. The focal point is the role that the 
cellular transcription factor Nuclear Factor I (NFI) plays in the 
formation of this nucleoprotein complex which is involved in the 
initiation of Ad2 DNA replication.
ADENOVIRUSES
Adenoviruses were discovered during attempts to establish tissue 
culture lines from tonsils and adenoidal tissue from children by Rowe et 
al, (1953) when they realised that a new virus was causing the 
degeneration of the cells. Hilleman and Werner (1954) isolated a similar 
virus from cultured human tracheal cells whilst investigating respiratory 
illnesses in army recruits. Since then 47 distinct serotypes infecting 
humans have been recognised (Heirholzer et al,, 1991). Adenovimses 
belong to the family Adenoviridae which is divided into two genera 
according to their natural hosts. The Mastadenovirus genus includes 
human, simian, bovine, equine, porcine, ovine, canine and opossum 
viruses whereas the Aviadenovirus genus includes fowl and turkey 
viruses.
Originally human adenovimses were sub-group classified into 
four groups (I-TV) on the basis of their ability to attach to the erythrocyte 
receptor in rat or rhesus monkeys producing four hemagglutination 
patterns (Table 1). An alternative classification scheme (sub-groups A- 
F) was devised when it was discovered that Ad 12 could induce tumours 
in hamsters (Trentin et al,, 1962) and was based on the oncogenicity in 
rodents of the various serotypes (Table 1).
Oncogenic potential
Subgroup Hemagglutination groups Serotypes Tumors in animals
Transformation 
in tissue 
culture
IV (little or no agglutination) t (complete agglutination of monkey 
eryttirocytes)III (partial agglutination of rat 
erythrocytes)
II (complete agglutination of rat erythrocytes)
III
III
12.18,313.7.11.14.16.21.34.
35 
1.2.5.6
8,9.19.37.10.13.15,
17.19.20,22-30.32.33.36.37.38.
39,424
40.41
High
Moderate 
Low or none 
Low or none
Low or none Unknown
Percentage of 
G + C in DNA
48-49
50-52
57-59
57-61
57-59
TABLE 1. Classification schemes for human adenoviruses (Horwitz, 1990a).
Adenoviruses can infect and replicate at various sites of the 
respiratory tract as well as in the eye, gastrointestinal tract and urinary 
bladder. Most of the human disease is associated with only a third of the 
47 recognised serotypes and many infections are asymptomatic resulting 
in protective antibody formation. Table 2 describes the more common 
illnesses associated with Ad infections.
D isease Individuals m ost at risk
Principal
sero types
A cu te  feb rile  pharyngitis 
P h ary n g o co n ju n c tiv a l fever 
A cu te  resp ira to ry  d isease  
P n e u m o n ia  
P n e u m o n ia
E p id em ic  keratocon junctiv itis 
P ertu ss is -lik e  syndrom e 
A cute h em o rrh ag ic  cystitis 
G a s tro e n te r itis  
H epa titis
P e rs is te n c e  of virus in urinary 
tra c t
Infants, young children 1. 2. 3. 5. 6. 7
S chool-age children 3. 7. 14
Military recruits 3, 4. 7. 14. 21
Infants, young children 1 .2 . 3. 7
Military recruits 4. 7
Any age group  8. 11. 19. 37
Infants, young children 5
Infants, young children 11. 21
Infants, young children 40. 41
Infants and  children with liver transp lan ts L  2. 5
A cquired im m unodeficiency syndrom e 34, 35
(AIDS), o ther im m unosuppression, and 
bone m arrow  transplant recipients
TABLE 2. Illnesses associated with adenovirus infections (Horwitz, 1990b).
VIRION ARCHITECTURE
Adenoviruses are nonenveloped, regular icosahedrons (20 
triangular surfaces and 12 vertices) that are 65-80nm in diameter and can 
be divided into two major structural complexes called the capsid and the 
core (Valentine and Pereira, 1965; Brown et al., 1976). The capsid 
consists of three viral proteins which make up the icosahedral shell and 
the core contains the linear double stranded (ds) DNA genome 
(approximately 35kbp) plus associated proteins (fig 1). The number of 
proteins contained within the virion has been variously estimated at 
between 11 and 15 (Maizel et a i, 1968; Weber et al., 1977).
TERM INAL
PROTEIN VIRAL DNA
VIRION VIRION
POLYPEPTIDES
DISRUPTED
VIRION
FIGURE 1. Schematic model illustrating the architecture of the adenovirus particle. 
The SDS-PAGE pattern of the virion polypeptides is shown along with their 
proposed locations (Russell and Precious, 1982).
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THE VIRAL CAPSID
The capsid is composed of 252 subunits (capsomers) of which 240 
are hexon protein and 12 are pentons which are located at the vertices of 
the icosahedron. The hexon capsomere is actually made up of thiee 
indentical subunits (Gruther and Franklin, 1974) which are held tightly 
together by noncovalent interactions.
The sequence of the Ad2 hexon protein reveals a chain length of 
967 residues and a molecular mass of 109,058 (Akusjarvi et al., 1984). 
Hexon was the first animal viral protein to be crystallised (Pereira et 
a/.,1968) with the crystals produced having a tetrahedral shape. 
Subsequent X-ray crystallographic studies of hexon have revealed that it 
has a total height of 11.6nm (Burnett et al., 1984) of which 5.2nm is a 
pseudo-hexagonal base which contains a central cavity and 6.4nm is a 
triangular top which comprises of three towers. Higher resolution X-ray 
crstallography (Roberts et al., 1986) showed that the hexon trimer is 
formed from three copies each of two very similar pedestal domains 
called PI and P2. Each pedestal domain consists of an eight stranded 
flattened 6 barrel and has four loop structures projecting from it. Loops 
LI, L2 (from PI) and L4 (from P2) foim one of the towers of the hexon 
trimer whereas L3 (from P2) does not protrude beyond the upper part of 
the base where it stabilises the interaction of the P domains within one 
subunit (fig 2). It is the three towers of the hexon trimer that contain the 
major antibody recognition sites which are important type specific 
antigenic determinants (Toogood et al., 1992).
The penton capsomere consists of a wide penton base and a long 
protruding fibre with a distal knob (Laver et al., 1969). The penton base 
is a pentamer of protein III (85kD) and has a diameter of approximately 
9.5nm at its widest point and a height of approximately 1 Inm (Ruigrok
3P2
#4#
I
FIGURE 2. A sketch of the hexon subunit viewed from within the central cavity of 
the trimeric molecule. The bottom of the molecule lies toward the adenovirus capsid interior and the top forms its external surface. The secondary structure has been 
overemphasised by drastically reducing the lengths of the connecting loops with the 
gaps being indicated by dashed lines. The two domains PI and P2 overlap through a 
very long p-strand forming hydrogen bonds with both domains. In each ^-barrel, an 
a-helix precedes the first strand and an a-helix is followed by a tower loop between 
the fifth and sixth strands. These loops are L2 rising from PI and L4 from P2 and 
both contain two antiparallel ^strands, those from L2 forming the Constriction 
about the molecular axis. The tower domain T is formed from three loops (LI, L2, 
L4), each from a different subunit. The bulk of the tower is provided by LI, an 
excursion in PI between the third and forth p-strands. Its counterpart in P2 is L3; 
although not as extensive , it is still the second longest connecting bridge of this 
barrel. Loop L3 is restricted to the upper part of the base, where it stabilises the 
interaction of the P domains within one subunit (Roberts eta/., 1986).
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et al., 1990). The fibre is a trimer of the 62kD protein IV (van Ostmm 
and Burnett, 1985; Ruigrok et al., 1990) the N-terminus of which non- 
covalently interacts with the penton base (Devaux et al., 1987; Boudin 
and Boulanger, 1982). Green et al. (1983) showed that the N-terminal 
region of the Ad2 fibre consists of 43 residues followed by a shaft region 
of about 357 residues and then a C-terminal knob of 181 residues. The 
shaft region contains a 15 amino acid repeat of which there are 22 in 
Ad2 but only 6 in Ad3 each of which adds 0.132nm to the shaft length 
(Ruigrok et al., 1990). The C-terminal knob like region contains the 
viral receptor-binding region and has a diameter of 4nm. Proteins Ela 
(66kD), VI (24kD), VIE (13kD) and IX (12kD) are also known to be 
associated with the capsid.
THE CORE
The core consists of the linear double-stranded (ds) DNA genome 
(35937bp in Ad2) plus associated proteins (V, VE, p and TP). The 
55kD terminal protein (TP) is covalently linked to the dCMP residue at 
the 5’ end of each strand of the DNA genome. The core proteins V 
(48.5kD) and VII (18.5kD) are basic proteins rich in arginine. VE 
accounts for approximately 14% of the viral protein and contains 21- 
23% arginine residues (Vayda et al., 1983) which is sufficient to cover 
about 60% of the phosphate charges of the viral DNA. There are 1070 
copies of VE and 180 copies of V in each core and they are referred to 
as the major and minor core protein, respectively (RusseU et al., 1968). 
The 4kD p protein is also rich in arginine (54%) and histidine (13%).
Several models have been proposed to explain the detailed 
arrangement of the DNA and proteins within the cores. Cores can be 
isolated preparatively by extracting whole virions with several different 
agents including 0.5% deoxycholate, acetone, Sarkosyl or 10% pyridine.
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Cores prepared by Sarkosyl extraction contain the viral DNA plus 
protein VE whereas those isolated by other methods contain protein V as 
well.
Cores prepared by Sarkosyl extraction and examined by electron 
microscopy (Brown et al., 1975) led to the suggestion that they consist 
of twelve 21.6nm spheres which are found at the vertices of the capsid 
icosahedron. Newcomb et al. (1984) used ion etching to erode the 
virion capsid so that the core could be examined by electron microscopy. 
They also found that the virion core consists of 12 spheres that they 
called adenosomes which are positioned towards the vertices of the 
icosahedron capsid.
The Nucleosome Model suggests that the DNA is packaged in 
structures similar to cellular nucleosomes where weU defined lengths of 
DNA (200bp) are complexed with an octamer of histones. Corden et al. 
(1976) used micrococcal nuclease (which cleaves between nucleosomes) 
to investigate the structure of the Ad core in pentonless virions. They 
found that the Ad genome was cut into 180 units of about 200bp and 
calculated that each DNA unit would be complexed with six copies of 
VE and one copy of V similar to cellular nucleosomes. Later 
experiments by Mirza and Weber (1982) involved electron microscopy 
on micrococcal nuclease digested pyridine cores. They proposed that 
180 units are spaced at irregular intervals along the Ad genome each 
consisting of approximately 150bp of DNA wrapped around three 
dimers of VE and about 30bp of linker DNA interacting with one copy 
ofV.
More recent experiments (Wong and Hsu, 1989) showed that the 
adenovirus virion DNA is organised in torsionally stressed, supercoiled 
loops. They digested pentonless cores with the nuclease Bal31 which 
has supercoiling-dependant endonuclease activity as weU as extracting
12
Ad DNA from virus particles that had been crosslinked with psoralen. 
As a result they have proposed a loop-domain model where the DNA is 
organised into eight supercoiled loops which are anchored to the center 
of the virus core by proteins. The ends of the genome containing the 
two origins of replication and the promoters of E la  and E4 are not 
thought to be contained within supercoiled domains because of their 
insensitivity to Bal31 digestion (fig. 3).
13M
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FIGURE 3. The Wong and Hsu (1989) loop domain model for the organisation of 
Ad5 DNA in the virus particles. EÎ-E4 represent Ad5 early genes, L1-L5 represent 
late genes and MLP is the major late promoter. DNA at the two ends of the Ad5 
genome containing promoters of Ela and E4 as well as replication origins are shown 
outside of supercoiled domains because of their insensitivity to Bal31 digestion.
Futhermore Wong and Hsu (1990) have shown that these supercoiled 
loops are found in intracellular Ad DNA by the observation of 
compensatory supercoiling of portions of Ad DNA when the DNA 
double helix was unwound through the intercalation of ethidium 
bromide. Their observation that the packaging of Ad DNA into virus 
particles was inhibited by topoisomerase II inhibitors suggests that 
topoisomerase II maybe involved in core assembly.
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LYTIC INFECTION
Adenovirus infection has a great effect on the host cells with cell 
DNA synthesis and protein synthesis being inhibited in adenovirus 
infected ceUs (Hodge and Scharff, 1969; Pina; Green, 1969). Lindberg 
et al, (1972) suggested that the inhibition of cell protein synthesis could 
in part be due to the depletion of cell mRNA from late cytoplasmic 
polyribosomes. However primary transcription of host cell sequences is 
still active in the nucleus of adenovirus infected cells and in fact this 
RNA makes up 80-90% of the nuclear transcripts (McGuire et al., 1972; 
Price and Penman, 1972). It has been shown that suppression of cellular 
tianslation requires progression into the late phase of infection but does 
not involve alterations in cellular mRNA stability or translatability in 
vitro (Babich et a i, 1983). Adenovirus infection blocks the transport of 
cellular RNAs from the nucleus to the cytoplasm at late times after 
infection (Beltz and Flint, 1979) however this does not significantly 
reduce the level of most cell mRNAs although their translation is 
inhibited (Babich et al., 1983). It is thought that the extremely effective 
inhibition of protein synthesis involves a translational control 
mechanism that discriminates between late viral and cellular mRNAs. 
Adenovirus late mRNAs all possess a common 200 nucleotide 5' 
noncoding region called the tripartite leader which enhances translation 
of most mRNAs (Logan and Shenk, 1984; Mansour et al., 1986). The 
presence of the tripartite leader on mRNAs allows them to be translated 
without the critical initiation factor CBP (cap-binding protein) complex 
(eIF-4F) (Dolph et al., 1988; 1990), Factor 4F functions as a cap- 
dependant RNA helicase required for translation of most capped RNAs 
so that indépendance from 4F activity would provide a means by which 
Ad late mRNAs can be distinguished from cellular and Ad early 
mRNAs. The CBP complex (eIF-4F) is composed of eIF-4A, eIF-4E
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(CBP) and p220. Huang and Schneider (1991) demonstrated that the 
inhibition of the translation of cellular mRNAs and possibly adenovirus 
early mRNAs is a result of a decrease in the phosphorylation of CBP and 
the subsequent inactivation of the CBP complex.
Viral DNA synthesis begins at 6-9 hours after infection 
whereupon cellular DNA synthesis is gradually inhibited. One 
suggestion is that inhibition could be a side effect of cellular protein 
synthesis shut off. Alternatively Hodge and Scharff (1969) found that 
when Ad DNA synthesis was timed to start during G1 there was no 
cellular DNA synthesis in the following S phase whereas when Ad DNA 
synthesis was timed to start during S phase then cellular DNA synthesis 
was normal for many hours. This suggests that Ad infection inhibits the 
initiation of cellular DNA synthesis but can not interupt it. Certainly the 
cellular chromatin is visibly displaced within adenovims infected nuclei 
to the margins of the nucleus, excluded from viral replication sites 
(Puvion-Dutilleul and Puvion, 1991).
CELL INVASION
Adenovimses are internalised via receptor mediated endocytosis 
where the C-terminal head portion of the Ad fiber is thought to attach to 
specific receptors on the cell membrane (Londberg-Holm and Philipson,
1969). The vims migrates within the plasma membrane to clathrin 
coated pits which form endocytic vessicles or receptosomes. 
Receptosomes have an internal pH of 5.0 which causes a conformational 
change in the hexon protein so that hydrophobic regions are exposed 
(Everitt et al., 1988) resulting in the mpture of the receptosome 
membrane on contact with the virions. The vims is then thought to be 
transported across the cytoplasm via an interaction between hexon and 
the microtubules (Dales and Chardonnet, 1973; Luftig and Weitung,
15
1975). At the nucleur pores uncoating of the virus is completed and the 
DNA plus closely associated proteins enter the nucleus whereupon 
adenovirus transcription can begin.
ADENOVIRUS TRANSCRIPTION
Human adenovims genomes consist of linear ds DNA which 
range in size from 34300bp in A d i2 to 35937bp in Ad2 and although 
there is substantial sequence diversity between the serotypes the basic 
genetic organisation is the same. Figure 4 shows the positions of the 
major transcripts on the Ad2 genome which has been divided up into 
100 map units (mu) to make describing their locations easier.
The infectious cycle can be divided into early and late phases with 
the dividing line being the onset of viral DNA replication which occurs 
at 6-9 hours post infection. The exact controls of this are not fully 
understood although Thomas and Mathews (1980) found that the switch 
mechanism is a cis-acting function of the viral DNA itself. The late and 
early phases can be further divided into immediate early (Ela); delayed 
early (Elb, E2a, E2b, E3, E4); intermediate (DC, IVa2) and late (L1-L5) 
phases. These are misleading descriptions of adenovims transcription 
which really only indicate when the peak amount of a transcript is 
produced. Experiments using the protein synthesis inhibitor anisomycin 
(Lewis et aL, 1980; Shaw and Ziff, 1982) indicated the presence of two 
mRNA species that are independant of E la function. These are a 
mRNA for a 13.5kD protein encoded between 17.0 and 21.5 map units 
and the LI mRNA for the late 52-55kD protein encoded between 29 and 
34 map units. Although LI is considered a late gene in reality it is the 
earliest gene expressed and expressed at about the same level as other 
early genes although at late times post infection its expression is greatly 
increased.
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FIGURE 4. A transcription and translation map of the Ad2 genome. By convention 
the r-strand is transcribed from left to right and the 1-strand is transcribed from right 
to left. The virion structural proteins are designated by roman numerals whereas the 
nonstructural proteins are designated in kiloDaltons (Horwitz, 1990a).
AH the mRNA transcripts that code for polypeptides are 
synthesised by cellular RNA polymerase II and are capped and 
polyadenylated before being transported to the cytoplasm (Philipson et 
al., 1971). However there are two small RNAs which have considerable 
secondary structure which are synthesised from the r strand at map units 
28,8 and 29.5 by cellular RNA polymerase IE. These are called virus 
associated (VA) RNAI and VA RNAE and are 155 (Ohe and Weissman,
1970) and 158-163 nucleotides long respectively. VA RNAI is required 
for efficient initiation of translation with protein synthesis being 
decreased 10 fold in cells infected with Ad mutants that do not have VA 
RNAI (Thimmappaya et al., 1982). Mutants which do not have VA
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RNAn show no such decrease but mutants which have neither VA RNA 
are 5-6 times more affected than those lacking VA RNAI alone (Bhat 
and Thimmappaya, 1982). This suggests that in the absence of VA 
RNAI VA RNAII is able to compensate in some way. VA RNAI is 
involved in blocking an interferon-induced mechanism of inhibiting 
protein synthesis after infection (Kitajewski et aL, 1986; O'Malley et al., 
1986) . Interferon induces higher levels of the cellular protein kinase 
DAI (for double stranded RNA-activated inhibitor) which 
phosphorylates the a-subunit of the initiating factor eIF2 thereby 
inhibiting protein synthesis. VA RNAI has been shown to bind directly 
to DAI thereby inhibiting its activation (Katze et al., 1987; Galabru et 
al., 1989).
Region E l
The E l region is located on the r strand at 1.3-11.2 map units and 
can be subdivided into E la at 1.3-4.5 map units and E lb  at 4.6-11.2 map 
units. The E l region codes for the transformation function of the 
adenoviruses so that in Ad2 E la  is required for the immortalisation of 
cells in tissue culture but E lb  is required for full transformation (Ruley, 
1983; Kelekar and Cole, 1987).
Five mRNAs are transcribed (commencing at about 45min post 
infection and reaching a maximum at 3-4 hours post infection) from the 
E la  region with sedimentation coefficients of 13S, 12S, IIS , lOS, and 
9S (Nevins, 1987; Stevens and Harlow, 1987; Ulfendahl et al., 1987). 
They are all (except the 98 transcript) translated in the same reading 
frame and have the same 5' and 3' ends but they are diffentiaUy spliced 
(Perricaudet et al., 1979; Boulanger and Blair, 1991). 138 and 128 are 
produced early and late in infection whereas 98 is only produced late in 
infection (Spector et al., 1978). The primary translation products of 138
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and 12S are 289 and 243 amino acids long respectively and give rise to 
more than six polypeptide species (38-5 IkD) as a result of 
postranslational modifications (Richter et aL, 1988). The only 
difference between the 289 and 243 amino acid polypeptides is a 46 
amino acid internal conserved region between amino acids 140-185 in 
the 289 amino acid species (Perricaudet, 1979). The 138 product 
contains three highly conserved domains and a nuclear localisation 
sequence at the C-terminus with only domain 3 being absent in the 128 
product (Moran and Mathews, 1987). Mutations in domain 2 greatly 
reduce the ability of the E la  products to induce mitosis or proliferation 
of primary cells (Zerler et aL, 1987). The transformation function of 
E la  is located within domain 2 and although, for example, A d i2 and 
Ad5 can transform cells in tissue culture only Ad 12 is oncogenic in 
animals. Bernards et aL (1983) and 8chrier et aL (1983) used 
transfection with E la segments from Ad5 or Ad 12 in the presence of an 
active E lb  gene to show that only the A dl2 E la  turns off the synthesis 
of class I major histocompatibility (MHC) polypeptides allowing the 
transformed cells to survive in the presence of cytotoxic T lymphocytes 
due to the down-regulation of MHC. Domain 1 seems to be involved in 
inducing DNA synthesis. Domain 3 which is unique to the 138 product 
is the primary transactivator of early viral genes (Moran et al,, 1986). 
E la  products are unable to bind directly to DNA (Ferguson et aL, 1985) 
and so must modify the activity of cellular transcription factors. One 
example of a cellular transcription factor involved in the E la  regulation 
of gene transcription is E2F. E2F undergoes a dramatic change in 
activity during adenovirus infection (Kovesdi et aL, 1986) which is 
mediated by Ela. The 19kD E4 gene product interacts with E2F 
enabling it to bind to the E2 promoter so that transcription can proceed 
(Huang and Hearing, 1989; Bagchi et aL, 1990; Raychaudhuri et aL,
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1990). However the retinoblastoma gene product inhibits E2F DNA 
binding by interacting with it (Bagchi et al., 1991) and thereby its 
transcriptional activity by interacting with i t . E la disrupts this 
interaction thereby freeing E2F to bind to the E2 promoter along with 
the 19kD E4 gene product resulting in a marked stimulation of 
transcription.
Transcription from E lb  is transactivated from E la  at 1,5-2 hours 
post infection reaching a maximum at 6-7 hours post infection. A 
primary transcript is produced which is differentially spliced to give 
products 22S, 14.5S, 14S and 13S which all have identical 5’ and 3' 
termini (Virtanen and Peterson, 1985). Three polypeptides are coded for 
with sizes 19kD, 20kD and 53-58kD. Both the 19kD and the 53-58kD 
proteins are involved in transformation along with Ela. The 19kD 
protein was found (White and Cipriani, 1989) to specifically disrupt both 
intermediate filaments and the nuclear lamina which could affect cell­
cell attachment and growth regulation thereby promoting anchorage 
independant growth and tumorigenicity. The 19kD protein also has 
transactivating functions for Ela, E lb, E2, E3 and E4 as well as for the 
cellular heat shock protein promoter (hsp 70). When the 19kD protein is 
defective the host DNA is degraded and the Ad cytopathology is 
increased (White and Stillman, 1987). The 53-58kD protein binds to the 
cellular tumour suppressor protein p53 (Samow et al., 1982) a mutated 
form of which is found in large amounts in transformed cells. The 53- 
58kD protein also interacts with the E4 34kD protein both of which are 
reqired for the efficient production of viral DNA, the expression of late 
viral genes and host cell shut-off (Halbert et aL, 1985).
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Region £2
The E2 region is located on the 1 strand at 11.3-75.4 map units and 
can be divided into E2a at 61.5-75.4 map units and E2b at 11.3-75.4 map 
units from both of which transcription starts at 1.5-2 hours post infection 
and peaks at 6-7 hours post infection.
E2a codes for the 72kD DNA binding protein (DBF) which is a 
multifuctional phosphoprotein which binds specifically to ssDNA as 
well as to dsDNA although with a lower affinity. It is required for Ad 
DNA replication both in vivo and in vitro which will be discussed later. 
The N-terminus of DBF is not required for DNA replication but has 
been shown to have a role in the regulation of transcription (Klessig and 
Quinlan, 1982).
E2b codes for the 80kD precursor to the terminal protein (pTP) 
and the 140kD DNA polymerase (pol) both of which are mquired for 
DNA replication and will be discussed later.
Region E3
The E3 region is located on the r strand at 76.6-86 map units from 
which transcription commences ar 1.5-2 hours post infection and reaches 
a maximum at 3-4 hours post infection. At least six mRNA species have 
been identified (Ross et aL, 1980) coding for a number of proteins which 
are nonessential in tissue culture but are involved in modulating the host 
response to adenovirus infection. For example a 19kD protein binds to 
the MHC polypeptide heavy chain in the endoplasmic reticulum and 
prevents tlieir transport to the cell surface thereby decreasing the target 
for recognition of infected ceU antigens by cytotoxic T lymphocytes 
(Burgert et aL, 1987). Another example of how Ad by-passes the host's 
antiviral mechanisms is carried out by the 14.7kD protein which inhibits 
the lysis of Ad infected cells by tumour necrosis factor (Gooding et aL,
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1988) also the 10.4kD protein binds to and thereby down regulates the 
epidermal growth factor receptor (Carlin et aL, 1989).
Region E4
The E4 region is located on the 1 strand at 91.3-99 map units and 
codes for a number of polypeptides, transcription commencing at 1.5-2 
hours post infection and peaking at 3-4 hours post infection. As 
mentioned earlier the 34kD protein binds to the 53-58kD protein of E lb  
(Halbert et aL, 1985). The 19kD protein transactivates E2 transcription 
by binding to the cellular factor E2F thereby increasing its affinity for 
the E2a promoter (Neill et aL, 1990). The 1 IkD protein was found to 
bind to the nuclear matrix and may have a role in DNA replication, 
transcription or RNA processing (Samow et aL, 1982).
Intermediate Transcription
The IX and IVa2 genes are located at the ends of the E lb  region 
and the E2b region respectively. Control of the intermediate transcripts 
is very complex since they are synthesised in large amounts at 6-8 hours 
post infection but are also synthesised in small amounts early in 
infection and late in infection (Horwitz, 1990).
M ajor Late Promoter (MLP)
The MLP is located on the r strand at 16.5 map units. It is active 
early in infection but transcription proceeds no further than map unit 39 
which is at the end of the LI region. At late times in infection 
transcription proceeds to map unit 99 through additional regions L2, L3, 
L4 and L5. All of the mRNAs initiated from the MLP possess a 
common 200 nucleotide 5’ noncoding region called the tripartite leader 
which enhances their translation (see under Lytic Infection).
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Regions L1-L5
The LI region is located on the r strand at 29-39 map units. Three 
mRNA species are produced starting at map units 29, 30.7 and 34 and all 
ending at map unit 39. These code for three proteins; plUa which is a 
precursor of the structural component of the viral capsid protein lUa and 
two phosphoproteins of 53kD and 55kD which are required for virion 
assembly.
The L2 region is located on the r strand at 39-50 map units. Three 
mRNA species are produced starting at map units 39.4,44.1 and 45.9 
and all ending at map unit 50. These code for a number of proteins 
including m  (penton base), pVn which is the precursor of the core 
protein VII, V (core protein) and an 1 IkD protein which is the precursor 
of the core protein p,.
The L3 region is located on the r strand at 50-62 map units. Three 
mRNA products have been identified which code for the proteins pVI 
which is the precursor protein of VI, II (hexon) and the 23kD cysteine 
protease which cleaves the precursor proteins pVI, pVII, pV ni and pTP 
during maturation of the virion (Webster et aL, 1989).
The L4 region is located on the r strand at 66.5-77.3 map units. 
Four mRNA products have been identified which code for the proteins 
lOOkD which is involved in the folding of hexon trimers (Gambke and 
Deppert, 1984), 33kD and pVin which is the precursor of the hexon 
associated protein VIII.
The L5 region is located on the r strand at 86-91.3 map units.
Two mRNA species are produced which code for protein IV (fiber).
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AKEN-QVIRVS-DM-BEEU C ATION
Adenovirus DNA replication is a highly structured process which 
takes place within nuclear globular 'replication compartments’ and 
begins at between 6 and 9 hours post infection coinciding with a 
reduction in host DNA synthesis of more than 90% (Horwitz, 1990). As 
previously mentioned the human adenovirus DNA genome consists of 
linear dsDNA which range in size between 34300bp in A d i2 to 35937bp 
in Ad2. At each end of the genome there is an inverted terminal repeat 
(ITR, Garon et al.., 1972) which ranges in size from 63bp in chicken 
embryo lethal orphan virus (Alestrom et al., 1982) to 165bp in human 
Ad 18 (Garon et al., 1982). The group C viruses Ad2 and Ad5 have 
identical ITRs of 103bp and are indistinguishable from each other with 
respect to their DNA replication. At each end of the genome the 55kD 
terminal protein (TP) is covalently attached to the 5' end of each DNA 
strand (Robinson et al., 1973; Challberg et al., 1980) via a 
phosphodiester bond between the B-OH of a serine residue in TP and the 
5' phosphate group of the terminal dCMP (Desiderio and Kelly, 1981).
A MODEL FOR DNA REPLICATION
Some early studies investigating the mechanism of adenovirus 
DNA replication involved pulse-labelling the termini of replicating 
DNA with ^H-thymidine and analysing the distribution of radioactivity 
in completed DNA molecules. Weingartner et al. (1976) determined 
that replication initiates at the 3' end of the parental template strand with 
each progeny strand being synthesised unidirectionally along its entire 
length possibly displacing the complementary parental strand. Wolfson 
and Dressier (1972) demonstrated that the Ad2 genome contains 
inverted terminal repeats (ITR) which allow the DNA to form a 
panhandle structure held together by hydrogen bonds between the two
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ITRs when it is rendered single stranded which could have a role to play 
in DNA replication. Electron microscopy of adenovirus DNA pulse- 
labelled with ^H-thymidine revealed two types of putative replicating 
DNA molecules (Lechner and Kelly, 1977). Type I consists of a duplex 
DNA molecule with one or more single stranded branches and type H 
consists of a duplex DNA molecule with a single stranded region 
extending from one end. They proposed that replication initiated at or 
near the ends of the adenovirus genome with progeny strand synthesis 
proceeding in the 5' to 3' direction displacing the complementary 
parental strand. Type I replicating molecules can be formed when one 
or more replication events are initiated at either or both ends of the 
DNA. Type II replication molecules can be formed in two ways one of 
which is when two oppositely moving replication forks meet resulting in 
separation of the parental strands. Alternatively type II replication 
molecules can be formed when replication is initiated at one end of the 
adenovirus genome and is completed before replication is initiated from 
the other end resulting in the non-template stand being displaced so that 
its replication is initiated from its 3' end.
When viral DNA was isolated using extraction procedures that did 
not contain proteolytic enzymes it was found to be circular or 
oligomeric. These complexes were disrupted with proteases or SDS to 
give the usual linear duplex formation leading to the conclusion that a 
protein is attached to each end of the viral genome (Robinson et aL, 
1973). Rekosh et aL (1977) demonstrated that this protein (Terminal 
Protein, TP) is 55kD in size and is covalently attached to the 5' ends of 
each DNA strand. They proposed a novel protein priming model for 
DNA replication where a newly synthesised molecule of TP binds to a 
region near the 3’ end of the parental strand. T hen, either before or after 
binding, it becomes covalently attached to the 5' terminal deoxycytidine
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of the progeny strand and acts as a primer for DNA replication. This 
model was modified when it was discovered that an 80kD protein is 
covalently attached to the 5’ ends of the progeny DNA rather than the 
55kD TP (Challberg et al., 1980). They suggested that this 80kD protein 
is a precursor of TP (pTP) which is cleaved during virion maturation.
The primary initition event is the foraiation of a covalent linkage 
between the (x-phosphoryl group of the 5' teiminal residue dCTP and the 
P OH group of a serine residue in pTP. The 3' OH group in the pTP- 
dCMP complex then acts as a primer for synthesis of the progeny strand 
by pol which proceeds displacing the parental strand.
The displaced strand can either form a panhandle structure via its ITRs 
thereby recreating the adenovims replication origin from which 
replication can be initiated (Stow, 1982; Hay et al., 1984) or 
alternatively there is evidence that initiation can take place on a single 
stranded template (Harris and Hay, 1988; Kenny and Hurwitz, 1988) 
without the necessity of the panhandle structure formation.
REPLICATION IN  VITRO
In order to study the component requirements of initiation of 
adenovirus DNA replication the development of an in vitro initiation of 
DNA replication system was highly desirable. The first such in vitro 
system was developed by Challberg and Kelly (1979) and consisted of 
Ad DNA covalently linked to TP as a template plus a soluble extract 
from the nuclei of Hela cells infected with Ad5. Synthesis of progeny 
strands were initiated at the termini of the input template and elongation 
proceeded in a 5' to 3' direction at a rate comparable to that in vivo 
resulting in the formation of type I replicative intermediates. To further 
define the requirements for DNA replication active components from the 
system had to be purified and characterised. Initially it was recognised
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that the nuclear extract of Ad5 infected Hela cells could be replaced by 
cytoplasmic extracts of Ad infected cells plus nuclear extracts from 
uninfected cells (Ikeda et aL, 1980). This indicated that cellular 
components were required for Ad5 DNA replication as well as viral 
ones. It is now known that three virally encoded proteins (DBF, pTP 
and pol) and two cellular proteins are required for efficient Ad2 and Ad5 
DNA replication (reviews Hay and Russell, 1989; Salas, 1991).
ORIGIN OF DNA REPLICATION
In vivo experiments to define the minimum requirement for the 
origin of DNA replication were carried out (Hay et aL, 1984; Hay, 1985) 
whereby linear plasmid molecules containing copies of the Ad2 ITR 
were introduced into cells along with helper vims. By deletion analysis 
it was shown that the terminal 45bp of the Ad2 genome were required 
for viral DNA replication. This was confirmed when a series of vims 
genomes were constmcted with deletions in the left ITR (Hay and 
M^Dougall, 1986) and it was found that those vimses containing the 
terminal 45bp were fully infectious whereas those containing the 
terminal 36bp or less were not.
In Ad2 in vitro experiments allowed the origin of DNA 
replication to be divided into three domains, contained within the 
terminal 51bp of the viral genome, which each contribute to replication 
efficiency (fig. 5). Each of these domains contains the binding sites of 
viral and cellular proteins which assemble into a nucleoprotein complex 
at the origin of replication. The teiminal 18bp is referred to as the ’core’ 
of the origin of DNA replication and contains a lObp sequence (9- 
ATAATATACC-18) which is perfectly conserved in all human 
adenovimses sequenced to date (Tamanoi and Stillman, 1983; Challberg 
and Rawlins, 1984). In Ad2 this core region is absolutely required for
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A d .2 ori
YTATTTTGGAT TG AAGCCAAT 
T TAT TTTTTTTG TG TG AGTTA AT
—  Ad 4  o n  —
Figure 5. The origin of DNA replication of Ad2 and Ad4 showing the conserved core region and the NFI and NFIII recognition sites.
DNA replication but in isolation can only support a limited level of 
replication. Temperley and Hay, (1992) showed that the conserved 
region of the core is the binding site of the pTP-pol heterodimer. The 
second domain lies between bp 19 and 39 and contains the recognition 
sequence of the cellular protein Nuclear Factor I (NFI). In vitro 
experiments have shown that initiation of Ad2 DNA replication is 
stimulated 10 fold in the presence of NFI (Nagata et aL, 1982). In vivo 
experiments already mentioned demonstrate that if deletions are made 
into the NFI binding site then Ad2 DNA replication is abolished. 
Transfection experiments where a series of plasmids were constmcted 
where 0.5,1. 1.5. and 2 turns of the DNA helix were inserted between 
the NFI binding site and the core region of Ad2 were carried out (Bosher 
et al., 1990). Plasmids containing any of the inserted DNA sequence 
replicated only as well as plasmids containing the core region only 
demonstrating that the position of NFI in relation to the core is very 
important for efficient Ad2 DNA replication. The third domain lies 
between bps 40 and 51 and contains the recognition sequence of another 
cellular protein Nuclear Factor III (NFIII). The requirement for NFIII in
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Ad2 and Ad5 DNA replication is at present ambiguous since although in 
vitro experiments have shown that the addition of purified NFIII 
stimulates DNA replication 4-6 fold (Pruijn et aL, 1986) in vivo 
experiments have demonstrated that only the terminal 45bp are required 
for Ad2 DNA replication (Hay, 1985; Hay and M^Dougall, 1986).
More recently Coenjaerts et a/. (1991) created mutant origins and 
demonstrated that the insertion of two or more base pairs between the 
NFI and NFIH binding site abolished stimulation of replication by NFlll 
indicating that NFIIIs role in Ad2 replication is position dependant.
Since the stimulation of Ad2 DNA replication by NFIil is independant 
of NFI (Mul et aL, 1990) it suggests that the distance between it and the 
core region is critcal. The roles of NFI and NFIII will be discussed in 
more detail in a later section.
Unlike Ad2 Ad4 only requires the core 18bp for efficient 
initiation of DNA replication (Hay, 1985). It does not have an NFI 
recognition site within its ITR and addition of purified NFI to an in vitro 
replication assay does not stimulate Ad4 initiation of DNA replication. 
Although Ad4 does have an NFIII recognition site within its ITR it is not 
required for efficient initiation of DNA replication either in vivo (Hay, 
1985) or in vitro (Harris and Hay, 1988).
VIRAL REPLICATION PROTEINS
Three viral proteins are required for efficient initiation of 
adenovirus DNA replication. These are the DNA binding protein 
(DBP), the DNA polymerase (pol) and the preterminal protein (pTP).
DNA Binding Protein
DBP is a multifunctional phosphoprotein (Russell and Blair,
1977) that is coded for by the E2a region. It is produced in very large
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amounts (up to 5x10^ molecules per cell) early in infection and was first 
isolated by van der Vliet and Levine (1973) when they fractionated Ad 
infected and uninfected cell extracts by DNA-cellulose affinity 
chromatography. They originally purified two forms of DBP of sizes 
44kD and 72kD the smaller of which was later foimd to be a proteolytic 
product of the larger. DBP is absolutely required for elongation of Ad 
DNA (Friefeld et aL 1983) and has been shown using electron 
microscopy to be bound to ssDNA actively engaged in Ad DNA 
replication (Kedinger et al. 1978). One of the roles DBP plays in 
adenovirus DNA replication is to protect the non-replicated displaced 
strand from nuclease attack for which it can be replaced by other ssDNA 
binding proteins such as E. coli SSB (Lindenbaum et aL, 1986). Using 
the H5tsl07 DBP mutant Krevolin and Horwitz (1987) showed that 
DNA binding function was not sufficient to ensure that DNA replication 
would occur indicating that DBP may interact with another replication 
component. DBP stimulates poly(dA) synthesis by po 110-100 fold 
resulting in the synthesis of poly(dA) chains greater than 30kb 
suggesting that in the presence of DBP pol can synthesise the complete 
adenovirus genome (Field et aL, 1984). Using poly(dT).oligo(dA) 
templates Lindenbaum et al. (1986) showed that DBFs role in increasing 
the processivity of pol was independant of its ability to bind to ssDNA 
and can not be substituted by other ssDNA binding proteins. They 
suggested that a DBP-pol cooperative complex is capable of 
synthesising the entire adenovirus genome in a single binding event 
resulting in the displacement of the non-replicated strand. As yet no 
direct interaction between DBP and pol has been demonstrated.
DBP was originally classified as a single strand specific DNA 
binding protein but it is now known to bind to double stranded DNA as 
well. DBP has only a slightly higher affinity for ssDNA than it does for
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dsDNA but its dissociation from dsDNA is rapid whereas the complex 
with ssDNA is much more stable (Stuiver et aL, 1992) which indicates 
the possibility that two different binding methods are involved. Circular 
dichroism and optical density measurements have been used to study 
DBP binding to ssDNA and RNA. Various templates have been used 
and the size of the DNA-binding site has been found to range from 10 
nucleotides for M l 3 DNA to 10-11 nucleotides for poly(dA) to 13 
nucleotides for poly(rA) to 15 nucleotides for poly (dT) (van 
Amerongen et al., 1987; Kuil et al., 1989). The secondary structure of 
the DBP-ssDNA complex indicates that there is an increase in the length 
of the polynucleotides (as a result of a decrease in the rotation per base 
and/or the bases move closer to the helix axis) and a strong tilt of the 
bases as a result of DBP binding (van Amerongen et aL, 1987). The 
structure of the DBP-dsDNA complex was also studied using circular 
dichroism (Stuiver et aL, 1992) which revealed distortions in base-to; 
base positions of the DNA possibly reminiscent of those found in the 
DBP-ssDNA complex. Hydroxyl radical degradation confirmed that 
DBP distorts the DNA at the level of base-pair positions by the altered 
susceptibility of sugar residues to hydroxyl radical degradation (Stuiver 
et aL, 1992). These DBP induced distortions of the DNA may explain 
how DBP increases the processivity of pol since the helical distortions 
may reduce the energy required to separate the DNA strands at the 
replication fork.
The functional domains of DBP were mapped by chymotryptic 
and tryptic partial digests of the purified protein that had been 
extensively labeled in vivo with [32p]orthophosphate. Friefeld et aL 
(1983) found that a 34kD chymotryptic peptide from the carboxy end 
was completely functional for Ad DNA elongation and unlike the N- 
terminal region it is not phosphorylated suggesting that phosphorylation
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is not involved in DNA replication. Krevolin and Horwitz (1987) 
showed that the 34kD C-terminal domain of DBP is able to bind to 
ssDNA and that it is functional in in vitro DNA replication assays. The 
C-terminal domain of a number of adenovirus serotypes contain four 
conserved regions at positions 178-186 (CRl), 322-330 (CR2) and 464- 
475 (CR3) in the Ad5 sequence and position 273-286 in the Ad2 
sequence which may be involved in DNA binding (Vos et aL, 1988; 
Neale and Kitchingman 1990). The conserved region between amino 
acids 273 and 286 consists of a symmetrical arrangement of two 
Cysteine (Cys) and two Histidine (His) residues. This HXCXgCXH 
motif shows some similarity to several proposed metal-binding sites and 
since it contains two out of the three conserved His. residues and two ts 
mutants are located between the two Cys-His pairs it seems likely that it 
is (Vos et aL, 1988). This was confirmed when DBP was shown to bind 
specifically to Zn^+ even in the presence of other divalent ions such as 
Ca^+, Mg2+, Cd^+, Co^+ and Mn^+ (Eagle and Klessig, 1992). Mutants 
were constmcted which had the region 273-286 deleted or a point 
mutation of Cys. to Ser at position 284. The deletion mutant was unable 
to bind zinc and ssDNA-cellulose and the point mutant was only able to 
bind zinc and ssDNA-cellulose with decreased ability (Eagle and 
Klessig, 1992). Cleghon and Klessig (1992) used limited proteolysis 
followed by ssDNA-cellulose chromatography and amino acid sequence 
analysis to isolate the ssDNA fragment of DBP. They obtained a 
fragment af 35kD which consisted of amino acids 153 to approximately 
470. Previously Tsemoglou et aL (1985) isolated a chymotrytic 
fragment of amino acids 174 to 525 which is able to substitute for native 
DBP in in vitro DNA replication assays. Combining this information 
suggests that the DNA binding domain of DBP is localised to amino 
acids 174 to approximately 470 which contains all four of the conserved
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regions. DBP was photochemically cross-linked to the oligonucleotide 
p(dT)i4  so that the contact points between DBP and ssDNA could be 
identified (Cleghon and Klessig, 1992). These were found to be 
methionine 299 and phenylalanine 418. Methionine 299 is only 13 
amino acids away from the zinc-binding region which could be involved 
in maintaining the proper local conformation to allow mehionine 299 to 
make contact with the DNA (Eagle and Klessig, 1992). Phenylalanine 
418 contact with ssDNA supports the idea that aromatic residues are 
involved in binding to ssDNA by the stacking of aromatic residues 
between the nucleic acid bases (Cleghon and Klessig, 1992). It is also 
positioned between the conserved regions CR2 and CR3 which have 
both been shown to be involved in DNA binding (Neale and 
Kitchingman, 1990).
In the past there was some controversy over whether or not DBP 
has a stimulatory affect on initiation of DNA replication. Early work 
involving the DBP ts mutant H5tsl25 found that nuclear extracts of 
infected cells grown at the non-permissive temperature were blocked in 
elongation but allowed the formation of the pTP-dCMP intiation 
complex suggesting that DBP is not required for initiation. Some 
workers have failed to demonstrate that addition of DBP to in vitro 
initiation assays results in stimulation (Rosenfeld et aL, 1987) whereas 
others have demonstrated just such a stimulation (Kenny and Horwitz,
1988). The confusion seems to be centred on the amount of NFI used in 
the assays. Cleat and Hay (1989) and Stuiver and van der Vliet (1990) 
showed that DBP can stimulate the frequency of initiation of Ad2 DNA 
replication when NFI is present in non-saturating amounts. DBP 
increases the affinity NFI has for its recognition site (Cleat and Hay,
1989) probably by altering the DNA stmcture so that base-specific 
contacts by NFI are brought into better alignment (Stuiver and van der
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Vliet, 1990; Stuiver et a i, 1992). An added complication involves Ad4 
which does not require NFI for efficient initiation of DNA replication 
suggesting that DBP would have no effect on initiation. However Ad4 
DBP has been found to stimulate initiation of Ad4 DNA replication in in 
vitro assays (Temperley and Hay, 1991) indicating that DBP stimulation 
is not confined to increasing NFI binding.
Adenovirus DNA Polymerase
Initially polymerase activity, that was distinguished from those of 
HeLa cell DNA polymerases a , |3 and y, was copurified with 
preparations of pTP from adenovirus infected HeLas (Enomoto et aL, 
1981). It resembled DNA polymerase a  in its sensitivity to N- 
ethlymaleimide, NaCl and cytosine p-D-arabinofuranoside-5'- 
triphosphate but unlike polymerase a  it proved to be insensitive to 
aphidicolin aU of which suggested that adenoviruses code for their 
own DNA polymerase. It was ascertained that the 80kD pTP forms a 
very tight heterodimer with a protein of 140kD which requires glycerol 
gradient sedimentation in the presence of 1.7M urea to be broken (Lichy 
et aL, 1982). This 140kD protein is the adenovirus DNA polymerase 
which is coded for by the E2b region which is expressed early in 
infection reaching a maximum at 6-7 hours post infection just as Ad 
DNA replication commences. Shu et aL (1987) cloned and expressed 
full length active pol and found that the Hindlll-J fragment that encodes 
the exon at map position 39 (shared with pTP) is required together with 
the DNA fragment from 24.7 to 9.2 map units which contains an open 
reading frame for a protein of 120kD.
A unique function of pol is its ability to use pTP as a primer for 
DNA replication when it catalyses the transfer of dCMP directly to the 
pTP (Lichy et aL, 1982). Another distinctive property of pol is its DBP
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dependant elongation reaction on poly(dT).oligo(dA) template primers 
(Field et aL, 1984; Lindenbaum et aL, 1986). DBP stimulates the 
poly(dA) chain synthesis 10-100 fold and ATP further stimulates it 3-10 
fold. Under optimal conditions pol is a highly processive enzyme which 
can synthesise poly(dA) chains greater than 30kbp in length, that is, it is 
capable of synthesising DNA the size of the Ad genome. Added to this 
it also has a 3'-5' exonuclease activity (Field et aL, 1984) which could be 
associated with the high fidelity of DNA synthesis by removing 
nucleotides which are misincorporated.
Chen and Horwitz (1989) constructed various 16 linker-insertion 
Ad pol mutants to investigate whether the various pol activities are 
segregated into functional domains within the whole protein. They 
found that this is not the case and therefore propose that some of the 
separate regions on the linear Ad pol molecule interact to produce active 
sites that act as functional domains for the properties of pol. The Ad2 
pol sequence contains two potential zinc finger motifs (Cys-His-rich 
sequences) which may be involved in DNA binding (Chen et aL, 1990). 
The N-terminal (amino acids 228-256) proposed motif consists of 
COYC(aa)2 oHINSH and the C-terminal (amino acids 1056-1080) 
proposed motif consists of CGAC(aa)2 2 HCPSC. Several point and 
linker insertion mutants in these regions were expressed and analysed 
(Joung and Engler, 1992) in vitro for any effects on pol function. 
Mutants in the C-terminal region had a great effect on DNA synthesis, 
DNA binding and in vitro initiation. Mutants in the N-terminal region 
had a moderate effect on DNA synthesis and elongation but failed to 
make dCMP-pTP initiation complexes or to bind to DNA. They suggest 
that pol has two DNA binding domains: the C-teiminal domain is 
responsible for binding to DNA primer-template complexes whereas the
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N-terminal domain is involved in the recognition of adenovirus origin 
sequences.
Terminal Protein and Preterminal Protein
The 80kD pTP is coded for by the E2b region of the Ad genome 
early in infection, reaching a maximum at 6-7 hours post infection just 
as Ad DNA replication commences. pTP is specifically cleaved to the 
55kD TP via a 62kD intermediate by the Ad 26kD cysteine protease 
during maturation of the virion (Webster et aL, 1989). As already 
mentioned TP is covalently linked to the 5’ end of each DNA strand of 
the Ad genome via a phosphodiester linkage between serine residue 580 
and the first nucleotide dCMP (Robinson et aL, 1973; Smart and 
Stillman, 1982). The exact role of TP in adenovirus DNA replication is 
still unclear. Originally it was demonstrated that the attachment of TP to 
the Ad DNA greatly increases its infectivity (Sharp et aL, 1976) possibly 
by preventing nucleolytic degradation. In addition Ad DNA has been 
found to bind to the nuclear matrix of the host via TP (Schaack et aL, 
1990; Bodnar et aL, 1989). In addition Schaak et aL (1990) found that 
tight binding of TP to the DNA is correlated with efficient transcription 
probably as a result of its attaching the Ad genome to the nuclear matrix. 
Template DNA attached to TP can support levels of DNA replication in 
vitro up to 20 fold higher than template in isolation (Tamonoi and 
Stillman 1982; van Bergen et aL 1983; Challberg and Rawlins 1984; 
Harris and Hay 1988). It has been suggested that this may in part be due 
to an interaction with pTP thereby positioning the pTP-pol heterodimer 
at the origin of replication and indeed band-shift assays have shown that 
TP-DNA binds pTP-pol more efficiently than TP free DNA (Pronk and 
van der Vliet, in preparation; cited in Pronk et aL, 1992). Also TP may 
be involved in initial strand unwinding (Kenny et aL 1988) since in TP
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free templates there has to be a single stranded region at the end or the 
5'-3’ exonuclease activity or Factor pL is required for in vitro 
replication. Lichy et a/. (1981) demonstrated that the pTP of the pTP- 
pol heterodimer is the primer for Ad DNA replication when a covalent 
complex is formed between the B-OH of a serine residue in pTP and the 
phosphate of dCMP.
CELLULAR REPLICATION PROTEINS
Two cellular proteins are required for efficient initiation of Ad2 
and Ad5 DNA replication. These are the cellular transcription factors 
Nuclear Factor I (NFI) and Nuclear Factor HI (NFIII). In addition 
Nuclear Factor II (NFII) is required for complete elongation and Factor 
pL is required in some in vitro experiments..
Nuclear Factor I
Dceda et aL (1980) demonstrated that the nuclear extract of Ad5 
infected HeLa cells required by Challberg and Rawlins (1979) in their 
Ad5 DNA replication assay could be replaced by cytoplasmic extracts of 
Ad5 infected cells plus nuclear extracts from uninfected cells. This 
indicated that Ad5 requires at least one cellular component for efficient 
DNA replication. Nuclear Factor I (NFI) was isolated, characterised and 
named by Nagata et aL (1982) from extracts of uninfected nuclei. This 
apparent 47kD protein stimulates pTP-dCMP formation in Ad DNA 
replication assays and this NFI mediated stimulation is itself stimulated 
in the presence of DBP and/or ATP.
NFI was (Nagata et aL, 1983a) found to bind selectively to base 
pairs 17-48 near the terminus of the Ad5 DNA. Leegwater et aL (1985) 
further clarified the NFI recognition site as being between base pairs 24 
and 39/40 and showed that the stimulation of Ad DNA replication is
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dependant on NFI binding to its recognition site and that binding is 
affected by the DBP concentration. DBP stimulates Ad2/5 DNA 
replication via its affect on NFI binding by increasmg the affinity NFI 
has for its recognition site. It also increases the association rate and 
decreases the dissociation rate of NFI for its recognition site with the 
overall effect being that when NFI is in non-saturating amounts its 
recognition site occupancy is optimised at any given moment in the 
presence of DBP (Cleat and Hay, 1989). The NFI recognition site is 
adjacent to the core of the origin of DNA replication (bp 1-18) and for 
optimal activity in vitro the relative postions of the core region and the 
NFI recognition site is critical (Adhya et aL, 1986). NFI maximally 
stimulates pTP-dCMP formation when the DNA template contains the 
intact Ad2 or Ad5 origin. A reduced level of stimulation is still obtained 
when up to 2bp are removed or 3bp added to the origin between the core 
and NFI site but if there are any more deletions or additions NFI 
stimulation is abolished. Adhya et aL (1986) also found that the 
orientation of the NFI site had no effect on stimulation of DNA 
replication suggesting that NFI binds DNA in a symmetrical manner, for 
example, as a dimer. In contrast to Ad2 and Ad5 Ad4 does not have an 
NFI recognition site adjacent to the core region in its origin of DNA 
replication. Ad4 replication proteins are able to replicate Ad DNA 
efficiently and so do not require stimulation from NFI (Hay, 1985).
Jones et aL (1987) made the discovery that purified NFI and 
purified CTF (CCA AT -binding transcription factor), which are actually 
both families of proteins of sizes 52-66kD, are indistinguishable from 
each other in DNA binding properties, immunological cross-reactivity 
and in vitro stimulation of DNA replication and transcription initiation. 
They concluded that the terms NFI and CTF refer to the same family of 
proteins which stimulate RNA polymerase II transcription and initiation
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of Ad2/5 DNA replication via their binding to DNA control elements 
that contain the sequence motif GCCAAT. In reality the presence of a 
CAAT motif does not automatically result in strong NFI binding which 
seems to require the presence of a TGG(C/A) motif and a GCCAA motif 
separated by 6bp (Jones e ta l,  1987; Gronostajski, 1987). Site directed 
mutagenesis of the consensus sequence reduces ar abolishes NFI binding 
and mutagenesis of sequences just outside it modulates binding affinity 
(de Vries et aL, 1985; Leegwater et aL, 1985). Detailed contactpoint 
analysis of HeLa NFI (de Vries et aL, 1987) revealed that all but one of 
the contacts are accessible from one side of the helix and are made 
within two successive turns of the major groove with the phosphate 
backbone and G and T residues.
The family of proteins (52-66kD) which makes up NFI/CTF are 
thought to originate from a single gene in human cells which gives rise 
to at least three distinct mRNA species as a result of alternative splicing 
(Santoro et aL, 1988; Meisteremst et aL, 1989). Various clones of NFI 
(Santoro et a/., 1988; Meisteremst et aL, 1989) have been expressed and 
found to have virtually indistinguishable DNA binding activities and to 
stimulate initiation of Ad2/5 DNA replication in vitro ten fold much 
like HeLa NFI does. Mermod et aL (1989) mutagenised the cDNA 
encoding for the largest NFI protein (CTF-1) and identified the domains 
that are responsible for DNA binding, dimérisation and stimulation of 
Ad DNA replication. The 185 N-terminal amino acids of related NFI 
factors are highly conserved whereas the amino acids of the C-terminal 
half show significant divergence (Mermod et aL, 1989; Meisteremst et 
aL, 1988; Paonessa et aL, 1988). The N-terminal region is sufficient for 
site-specific DNA recognition, protein dimérisation and adenovims 
replication whereas transcriptional activation requires the additional 
proline rich C-terminal region (Mermod et aL, 1989). Possibly the
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proline residues are involved in specific interactions with other factors 
that play a role in the initiation of transcription but are not required for 
DNA binding or Ad DNA replication.
Nuclear Factor III
Pruijn et al. (1986) purified a cellular protein (NFIII) that 
stimulates initiation of Ad2 DNA replication 4-6 fold in vitro and has a 
recognition site in the Ad2 origin of DNA replication between 
nucleotides 36 and 54. Since NFFs recognition site is between 
nucleotides 24 and 39/40 (Leegwater et al., 1985) it appears that NFI 
and NFIII can partially overlap each other on the Ad2 origin when they 
bind simultaneously (Pruijn et al., 1986). Both proteins have contacts 
with nucleotide 39 for example (Pruijn et a/.,1988) with NFI contacting 
the T base in the major groove and NFin contacting the complementary 
A base in the minor groove as well as the phosphate backbone. In vitf'o 
experiments indicate that like NFI the 92kD NFin protein exerts its 
stimulatory effect on the level of initiation of Ad2 DNA replication 
(Pruijn et aL, 1986 and O’Neill and Kelly, 1988) with stimulation being 
dependant on NFIII binding to its recognition site in the replication 
origin (O’Neill and KeUy, 1988). Deletion of this site results in a 
decrease in the efficiency of initiation of Ad2 DNA replication in vitro 
to about 30% of the normal level. However unlike NFI the role of NFIII 
in stimulating Ad2 DNA replication in vivo is unclear since plasmids 
containing sequences 1-45 or 1-67 are fully active in replication in vivo 
(Hay and McDougall, 1986). The NFIII recognition site contains an 
octanucleotide sequence which is partially conserved in human 
adenoviruses at similar positions within the origin. Ad4 has the optimal 
binding consensus sequence of 5 -TATGCAAAT-3’ between nucleotides 
41 and 49 whereas the Ad2 sequence (5’-TATGATAAT-3') between
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nucleotides 39 and 47 has a relative binding affinity 2.5 times lower than 
Ad4 (Pruijn et a/.,1987). NFIII also binds to its consensus sequence 
present in a number of transcriptional regulatory elements, for example, 
the V h  promoter and the H2B promoter resulting in transcriptional 
activation (Pruijn et aL, 1987; O'Neill and Kelly, 1988).
Pruijn et aL (1989) demonstrated that NFIII and OTF-I 
(octamer transcription factor I) are the same protein when they showed 
that they have indistinguishable mobilities on SDS-polyacrylamide gels, 
both stimulate Ad2/5 DNA replication and antisera raised against OTF-I 
recognises NFIII as weU as inhibiting stimulation of Ad5 DNA 
replication by NFin. NFIII contains a central conserved DNA binding 
domain (POU domain) which is sufficient for stimulation of Ad2 
initiation of DNA replication although transcription requires additional 
regions as well (Verijzer et aL, 1990). The POU domain can be 
subdivided into an N-terminal 74 amino acid POU-specific domain and 
a C-terminal POU homeo domain. The POU homeo domain binds to 
DNA thereby inhibiting DNA replication which suggests that the POU- 
specific domain is responsible for stimulation of Ad 2/5 DNA 
replication and possibly contributes to DNA binding. The position of 
the NFin recognition site in the origin of DNA replication is critical 
(Coenjaerts et aL, 1991) with the insertion of two or more base pairs 
between the NFI and NFIII sites abolishing NFIII stimulation. This sort 
of strict spatial arrangement suggests an NFI-NFIII protein interaction 
however both proteins can stimulate initiation independantly and 
without steric hindrance (Mul et aL, 1990). Verrijzer et a/. (1991) have 
shown that NFIII is able to bend DNA via the POU-specific domain 
which could result in an altered origin structure that promotes pTP-pol 
binding to the core.
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Nuclear Factor II
A third cellular factor, Nuclear Factor II (NFII) is required for 
full elongation of the Ad DNA but is not required for efficient initiation 
of Ad DNA replication. NFII is a 30kD complex of two proteins of 
15kD and 17kD which has topoisomerase activity. In vitro assays 
demonstrate that on addition of NFII the DNA products are increased in 
size from 25-35% to the fuU length genome (Nagata et aL, 1983b). 
Purified eukaryotic topoisomerase I (lOOkD) can substitute for NFII and 
may represent either an active proteolytic fragment or a new type of 
eukaryotic topoisomerase I activity.
Factor pL
Factor pL is a 44kD protein that has 5'-3' exonuclease activity 
on both single stranded and duplex DNA (Kenny et a/.,1988). It is not 
thought to be involved in Ad DNA replication in vivo where TP is 
probably involved in initial strand unwinding but it is required in vitro if 
TP free templates are used. Then pL degrades the 5’ terminus of the 
displaced strand to create a single stranded region at the 3' end of the 
template strand.
REPLICATION COMPARTMENTS
NUCLEAR ARCHITECTURE
During the S phase of the eukaryotic cell cycle DNA replication 
takes place at discrete sites in the nucleus. For many years there was 
controversy over whether these replication sites are fixed to a nuclear 
sub-structure with the replicating DNA moving through them or if the 
replicating complex is unattached to the nucleoskeleton and progresses 
along the replicating DNA. The problem was that evidence for fixed
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replication sites came from experiments using cells that had been 
extracted in hypertonic salt concentrations that could result in the 
formation of artefacts that bear no resemblance to structures in vivo. 
There are many terms used to describe various nuclear structures which 
correlate with the extraction procedure used to obtain them, the most 
commonly used being defined as follows. The term nuclear matrix was 
first used to describe the residual framework obtained from rat liver 
nuclei by extraction with 0.2mM MgCla, 2M NaCl, detergent and then 
nucleases. This matrix consisted of 98.4% protein ,0.1% DNA, 1.2% 
RNA and 0.5% phospholipid (Berezney and Coffey, 1974). Today 
nuclei extracted simply with hypertonic salt bufifers are called nuclear 
matrices (Jackson, 1991), Whatever the exact method used they all 
shaie common structural characteristics such as residual elements of the 
nuclear envelope, residual nucleoli and a granular and fibrous internal 
matrix structure that extends throughout the nucleus (Verheijen et aL, 
1988). Nucleoids are prepared by gently extracting the protein from 
nuclei with non-ionic detergents and hypertonic salt solutions. Because 
nucleases are not used they contain the DNA and nearly all of the RNA 
of the nucleus but are depleted of most of their nuclear proteins(Cook et 
al., 1976). Due to concerns that structural information derived from 
nuclei that had been extracted with high salt buffers could be the result 
of artefacts led to more gentle procedures being developed. Nuclear 
scaffolds are prepared in low salt buffers that contain spermidine and 
lithium diiodosalicylate (LIS) which removes most of the histones and 
many other proteins but maintains the DNA in a folded conformation 
(Mirkovitch et aL, 1984). Finally the nucleoskeleton was developed 
(Jackson et aL, 1988) where the cells were first encapsulated in agarose 
microbeads which allows ionic detergents to extract nearly all the 
protein and RNA but leave the naked DNA. The cells are lysed and
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washed in a ’physiological’ buffer whose composition is approximately 
cytoplasmic. Since nucleoskeletons are prepared using mild conditions 
whilst protected by agarose with the preservation of nuclear function a 
priority they should be the least plagued by artefacts.
The initial experiments examining how chromatin is organised 
within the nucleus involved the analysis of nuclear matrices (Verheijen 
et aL, 1988) and nucleoids (Jackson et aL, 1984). Chromatin appears to 
be organised into domains or loops which are held together by a nuclear 
framework. However results from experiments using nuclear matrices 
and nucleoids were doubted because it was argued that DNA loop 
formation could have been an artefact created by hypertonic extraction.
Preparations of nuclear scaffolds were developed which do not 
involve hypertonic extraction to counter part of the artefact argument 
(Mirkovitch et aL, 1984). These preparations are histone depleted which 
allows complete restriction enzyme digestion of the DNA. The scaffold 
is composed of a number of nonhistone proteins which form a peripheral 
lamina with a complex internal network. The highly organised 
chromatin loops are attached to the nuclear scaffold at specific 
attachment sites that occur in nontranscribed spacer regions of the DNA.
The encapsulation of cells in agarose microbeads has allowed 
permeabilisation and subsequent manipulations to be carried out in a 
’physiological buffer' (Jackson et aL, 1988) which minimises the 
possibility of artefacts since significant ionic changes have been 
eliminated. This approach has revealed that chromatin loops have an 
average size of 85kb which is constant throughout the ceU cycle and is 
larger than those seen in nuclear matrices (48.4kb) and nuclear scaffolds 
(15kb) and smaller than those seen in nucleoids (123kb) (Jackson et aL,
1990). Analysis of these procedures demonstrated that treatment with 
2M NaCl used in the isolation of nuclear matrices and nucleoids resulted
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in the formation of larger loops probably by destroying some attachment 
sites whereas treatment with hypotonic buffers also used in the isolation 
of nuclear matrices significantly reduced loop size. The very small 
loops found in nuclear scaffolds were a result of 'thermal stabilisation' 
which was responsible for 5 out of 6 loops. Jackson et al. (1990) 
suggest that their preparations of nuclear skeletons reflect most the in 
vivo situation with the maintenance of isotonic coditions being critical. 
Their loops are free of nicks, gross nuclear morphology has been 
retained and they have nearly all the replicational and transcriptional 
activity of the cell (Jackson et aL, 1988) indicating that nuclear function 
has been preseiwed. The organisation of chromatin loops attached at 
specific sites to a nuclear protein framework suggests that nuclei are 
highly organised, integrated structures where nuclear architecture and 
function could be inextricably linked. (Jackson, 1991).
EUKARYOTIC REPLICATION COMPARTMENTS
DNA synthesis was shown to occur at several hundred discrete 
sites within the nuclei of eukaryotic cells in S-phase by pulse labelling 
replicating DNA with 5-bromodeoxyuridine in vivo (Nakamura et aL, 
1986; Fox et aL, 1991) or biotinylated dUTP in nuclei of permeabilised 
cells (Nakayasu and Berezney, 1989; Mills et aL, 1989). Each discrete 
centre of DNA synthesis was found to contain approximately 20 
replicating complexes. Time course experiments showed that DNA 
synthesis was initiated in the replication centres at the beginning of S- 
phase and continued for about an hour when a second wave of DNA 
synthesis was initiated at different sites (Nakamura et aL, 1986).,Jackson 
and Cook (1986) demonstrated that progeny DNA and active DNA 
polymerase did not electroelute from cells with most of the chromatin 
after they had been encapsulated in agarose microbeads, lysed and
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treated with endonucleases. They interpret this to mean that the 
replication complex is attached to the nucleoskeleton and that replication 
proceeds by the movement of DNA through the fixed replication 
complex. In support of this in vitro experiments by Nakayasu and 
Berezney (1989) demonstrated that even after the removal of histones 
and more than 90% of the chromatin from cells the replication centres 
were unmoved having been successfully labelled by incorporation of 
biotinylated-dUTP both before and after extraction. MiUs et aL (1989) 
were able to use Xenopus laevis eggextracts and sperm DNA for the in 
vitro reconstitution of nuclei. Biotin-dUTP incorporation revealed that 
they also contained discrete centres of replication numbering 100-300 
per nucleus. The nucleus replicates in about an hour with each 
replication centre containing 300-1000 replication forks. Since pulse- 
labelling at various times throughout the replication phase revealed a 
similar patem without a raised level of background they also suggested 
that replication complexes are immobilised at fixed sites and that DNA 
is passed through them. Leonhardt et aL (1992) demonstrated that the 
DNA methyltransferase (MTase) that methylates deoxycytidine is 
localised to sites of ongoing DNA synthesis in S-phase nuclei whereas in 
Gi and cells it has a diffuse nuclear distribution. They determined 
that MTase has a replication focus targeting seqence between amino 
acids 207 and 455 as well as a nuclear localisation signal between amino 
acids 72 and 92.
VIRAL REPLICATION COMPARTMENTS
The replication proteins of various eukaryotic viruses are also 
known to localise to discrete sites within the nucleus. Early 
immunofluorescence experiments demonstrated that adenovims early 
proteins or P antigens, which includes DBP, are not evenly distributed
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throughout the nucleus but are localised to discrete subnuclear sites 
(Hayashi and Russell, 1968). Later immunofluorescence experiments 
have shown that DBP (Sugawara et al„ 1977; Reich et a l, 1983) and pol 
(Sasaguri et a l, 1987) are localised to discrete sites within the nucleus of 
Ad infected ceUs. A small amount of DBP remains diffusely distributed 
throughout the nucleus and can be extracted with 1% NP40,150mM 
NaCl but the majority is contained within globular foci and requires 
further treatment with 2m NaCl to be extracted (Voelkerding and 
Klessig, 1986). However the formation of these globular foci are 
dependant upon ongoing viral DNA replication with treatment with the 
DNA replication inhibitor hydroxyurea abolishing tlieir formation. In 
situ DNA hybridisation with biotinylated Ad5 probes demonstrates that 
DBP (Voelkerding and Klessig, 1986) and pol (Sasaguri et a l, 1987) 
colocalises with Ad DNA. Murti et al, (1990) used immunogold 
electron microscopy to investigate the distribution of DBP, pol and pTP 
in Ad5 infected cells. They hypothesise that the replication complex is 
translocated from compact initiation foci which contain large amounts of 
pol and pTP and little DBP and ssDNA to larger elongation foci which 
contain large amounts of DBP and ssDNA and smaU amounts of pol and 
pTP. The morphology of Ad5 infected cells has been studied (Puvion- 
Dutilleul and Puvion, 1991) using in situ hybridisation with a 
biotinylated Ad5 DNA probe followed by immunogold labelling and 
electron microscopy to investigate the intranuclear distribution of 
replicating viral DNA. They report the existance of very small foci 
containing replicating viral DNA which develop into larger sites of 
accumulated viral single stranded DNA.
The existance of replication compartments in Heipes simplex 
virus (HSV-1) comes from immunofluorescence studies of the 
localisation of the viral DNA binding protein 1CP8 which is required for
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viral DNA replication. In cells where viral DNA replication has been 
inhibited by sodium phosphoacetate ICP8 is localised to small, discrete 
foci evenly distributed throughout the nucleus but in cells where viral 
DNA replication is proceeding ICP8 is localised to large, globular foci 
distributed throughout the nucleus (Quinlan et aL, 1984). These two 
types of foci have been named 'prereplicative sites' and 'replication 
compartments' respectively. Randall and Dinwoodie (1986) showed that 
ICP8, ICP4 (a transcriptional cofactor) and the DNA polymerase aU 
colocalise at sites of active viral DNA replication. Several cellular DNA 
replication proteins such as PCNA, SSB and pol a  as weU as the 
retinoblastoma protein and p53 have also been shown to colocalise with 
ICP8 in HSV-1 infected cells (Wilcock and Lane, 1991).
TRANSCRIPTION COMPARTMENTS
The traditional view of transcription is that a mobile RNA 
polymerase moves along the DNA (Miller and Beatty, 1969; McKnight 
and Miller, 1979) but more recently (Jackson et a/., 1981) studies using 
nucleoids indicated that transcription occurs as DNA passes through a 
transcription complex fixed to a sub-nuclear structure. As mentioned 
previously results from experiments involving nuclear derivatives such 
as nucleoids have to be cautiously assessed because of the possibility of 
artefacts. The use of preparations of nucleoskeletons circumvents the 
problems of artefacts since the cells are protected within agarose 
microbeads before lysing them in a physiological buffer (Jackson et aL, 
1988). When the sites of RNA synthesis were labeled using Br-UTP 
several hundred discrete sites were seen distributed throughout the 
nucleus which in late S-phase were distinct from replication foci 
(Jackson et aL, manuscript submitted for publication). These sites do 
not elute with most of the chromatin indicating that they are attached to
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a nuclear sub-structure. Puvion-Dutilleul and Puvion (1991) labelled 
sites of active transcription by short pulse tritiated uridine incorporation 
and found that active replication sites and single stranded DNA 
accumulation sites were also transcription sites although only 10-15% of 
nascent viral RNA was contained in the single stranded accumulation 
sites.
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METHODS AND MATERIALS
1. Cells and tissue culture media
A549 cells (human lung carcinoma cell line) and HeLa cells 
(human cervical carcinoma cell line) were grown as monolayers at 3 7 0 C 
in Glasgow modified Eagle’s Medium containing 50units/ml of 
penicillin and SOpg/ml of streptomycin (G-MEM, GIBCO) 
supplemented with 10% newborn calf serum (Sera Lab Ltd) and 
maintained post infection in G-MEM supplemented with 1% newborn 
calf serum.
Spodopterajrugiperda cells were maintained either as 
monolayers or suspension cultures at 28^0 in TCI00 medium (GIBCO) 
supplemented with 10% foetal calf serum (Sera Lab Ltd).
2. Virus stocks
Adenovims types 2 and 4 were obtained from R. T. Hay. A549 
cells were used to titrate vims by the method of Williams (1970).
Recombinant baculovims (Autographe californica) expressing full 
length Nuclear Factor I (N FIfl) and the DNA binding domain of NFI 
(NFIdbd) were also obtained from R. T. Hay (Bosher et aL, 1991). 
Recombinant baculovims expressing the adenovims type 5 preterminal 
protein (pTP) and DNA polymerase (pol) were obtained from E-L.
Winnacker. Titers of vims stocks were determined by plaque assay 
(Summers and Smith, 1987).
3. Antibodies
Monoclonal antibody cc72k B6-10 directed against the Ad2 DNA 
binding protein (DBP) was obtained from A. Levine (Reich et aL, 1983). 
Monoclonal antibodies M2, M37 and M73 directed against E la  and
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rabbit polyclonal serum containing antibodies against E la  were a gift 
from N. Jones.
Rabbit polyclonal serum containing antibodies against bovine 
RNA polymerase H were a gift from M. Dahmus.
Polyclonal antisera were raised in rabbits against purified NFIfl , 
NFId b d , DBP (obtained from I. Leith), pTP and pol (both obtained from 
S. Temperley). 100jig of purified protein in 1ml PBS was mixed with 
1ml of Freund's complete adjuvant (SIGMA) and sonicated until a 
white, viscous emulsion had formed. Two Dutch rabbits were each 
subcutaneously injected with half of this emulsion. The rabbits were 
given booster injections every two weeks as before except that Freund's 
incomplete adjuvant (SIGMA) was used. 5ml of blood was removed 
from the rabbit's ears before the initial immunisation (pre-immune sera) 
and one week after subsequent immunisations (test sera). The blood 
collected was allowed to clot at 4^C overnight and tthe sera separated by 
centrifugation at 10(X)rpm for 10 min and stored in 0.5ml aliquots at 
-70OC.
5. Preabsorption of polyclonal antisera, raised against Ad2 
replication proteins
A confluent monolayer of HeLa or A549 cells were fixed with 
formaldehyde and permeabilised with NP40 as described in the 
Immunofluorescence method. The polyclonal antisera raised against 
DBP, pTP or pol was diluted 1 in 3 with 1% newborn calf serum, 0.1% 
sodium azide in PBS and poured onto the monolayer of cells. This was 
placed on a rocker and left for two hours at room temperature (RT) or 
overnight at 4^0. The antisera was then removed and filter sterilised 
and stored at -20OC.
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6. Affinity purification of polyclonal antisera raised against cellular 
proteins
1ml HiTrap NHS-activated columns (Pharmacia) were used to 
prepare affinity chromatography columns for the purification of 
polyclonal antisera raised against cellular proteins. The purified protein 
was coupled to the NHS-activated Sepharose according to the 
manufacturers instructions before purification was carried out.
The affinity column was pre-equilibriated with lOmM Tris-HCl, 
pH7.5. lOOjJil of polyclonal antisera was microfuged for 3 min to clear 
any debris and then diluted 1 in 10 with lOmM Tris-HCl, pH7.5. This 
was loaded onto the column and left for 60 min to maximise antibody- 
antigen binding. The column was washed with 10ml of lOmM Tris- 
HCl, pH7.5 followed by 10ml of lOmM Tris-HCl, 500mM NaCl, pH7.5. 
The bound antibodies were eluted using ten 1ml aliquots of l(X)mM 
triethylamine, pH ll.5  and were collected in l(X)]il of Tris-HCl, pH8.0. 
The presence of specific antibodies in the eluates was tested for by 
Western Blot analysis.
7. SDS polyacrylamide gel electrophoresis
Bio-Rad Mini Protein System Gel Rigs were assembled and used 
as directed by the manufacturers instructions. 10% running gels were 
made up using a 30% acrylamide stock (29.25% acrylamide, 0.75% 
N,N'-methylene-bis-acrylamide) and contained 0.375M Tris-HCl, pH8.9 
and 0.1% SDS. Polymerisation was carried out by the addition of 1/250 
volume of 25% (w/v) ammonium persulphate (APS) and 1/25(X) volume 
of TEMED (Kodak). Running gels were overlayed with isopropanol to 
ensure an even surface and was rinsed off with H 2 O after the gel had 
fully polymerised. The stacking gel contained 5% acrylamide in 
0.105M Tris-HCl, pH6.7 and 0.1% SDS. Samples to be loaded onto the
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gel were first denatured by heating at lOO^C for 3 min in buffer 
containing 30% (v/v) glycerol, 15% (v/v) b-mercaptoethanol, 6% (w/v) 
SDS, 0.128M Tris-HCl, pH6.7 and 0.05% bromophenol blue. 
Electrophoresis was carried out at 100 volts in an electrophoresis buffer 
consisting of 0.19M glycine, 0.025M Tris-HCl and 0.1% SDS.
8. Preparation of cytoplasmic and nuclear extracts
Cells (either A549 or S.frugiperda ) were grown as monolayers in 
90mm diameter dishes to 80% confluence. A549 cells were infected at 
lOpfu/cell with Ad2 and were harvested at various times post infection 
(0 ,12 ,24 , 36 or 48 hours). S. frugiperda ceUs were infected at 
lOpfu/ceU with the appropriate protein (pol or pTP) expressing 
recombinant baculovims and were harvested at 72 hours post infection. 
To harvest cells were scraped into the media and collected by 
centrifugation. The cells were washed twice with PBS and then lysed on 
ice in 50pl of 25mM Hepes, 5mM KCl, ImM dithiothreitol (DTT), 
0.5mM MgCl2, ImM sodium metabisulphite (SMBS), ImM 
phenylmethylsulphonylfluoride (PMSF), 0.5% NP40, ImM benzamidine 
and lOpg/ml of antipain, pepstatin and leupeptin for 30 min. The nuclei 
were collected by centrifugation in a microfuge for 3min and the 
cytoplasmic extract removed. Nuclei were lysed on ice in 50pil of 0.4M 
NaCl, 25mM Hepes, 5mM KCl, ImM DTT, 0.5mM MgCl2, ImM 
SMBS, ImM PMSF, 0.5% NP40, ImM benzamidine and lOpg/ml of 
antipain, pepstatin and leupeptin for 30 min and then the cell debris 
removed by centrifugation in a microfuge for 3 min and the nuclear 
extract removed. The protein content of the cytoplasmic and nuclear 
extracts were quantified by the method of Bradford (1976).
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9. Radiolabelling of a double stranded oligonucleotide for use in gel 
electrophoresis DNA binding assays
A double stranded oligonucleotide (obtained from R.T. Hay) that 
contained the NFI DNA binding site present in the Ad2 ITR (positions 
18-41) was 32p end labelled using the Klenow fragment of E.coli DNA 
polymerase (Amersham). 500ng of the oligonucleotide was incubated 
with 20nCi[a-32p]dCTP, 20|J.Ci[a-32p]dATP and unlabeUed dTTP and 
dGTP to final concentrations of lOOjiM in a buffer containing 50mM 
Tris-HCl, pH7,8, 5mM MgCl2, ImM DTT and lOOpg/ml (w/v) BSA 
with 10 units of Klenow for 15 min at 2Q0C. Then unlabelled dCTP and 
dATP were added to final concentrations of lOOpM and incubation 
continued for a further 15 min at 2Q0C. The reaction was stopped by 
addition of 1/5 final volume of 50% glycerol, lOOmM EDTA and 
bromophenol blue. Unincorporated dNTPs were separated from the 
labelled oligonucleotide by gel electrophoresis in an 8% polyacrylamide 
gel (29:1, acrylamide:N-N’-methylene-bis-aciylamide) and lOOmM Tris 
borate, ImM EDTA, pH8.3 and was polymerised by addition of 0.6% 
(v/v) of 25% APS and 0.06% (v/v) TEMED (Kodak). Gels were mn at 
200 volts for 45-60 min in IX TBE buffer. The band containing the 
labelled oligonucleotide was identified by autoradiography, excised 
from the gel and soaked in 500|Jil of lOmM Tris-HCl, O.lmM EDTA, 
l(X)mM NaCl, pH8.0 buffer overnight at 37®C to elute the DNA. 
Labelled double stranded oligonucleotide was stored at 4^C.
10. Gel electrophoresis DNA binding assays
Either lO-lOOng of purified NFI or nuclear extracts containing 
4pg (as determined by Bradford, 1976) of total protein were incubated 
with 20jxg BSA and Ipg of poly(dA.dT)poly(dG.dC) in 20pl of 150mM 
NaCl, 25mM Hepes-NaOH pH8,5mM MgCh, 20mM DTT and 0.01%
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NP40. After 15 min at 20^C ^^P end labelled double stranded 
oligonucleotide (l-2ng) containing the NFI DNA binding site was added 
and incubated at 20^0 for a further 15 min. For competition 
experiments the assay mixtures were incubated with an excess of 
unlabelled double stranded oligonucleotides containing the NFI, NFlil 
or NF-kB DNA binding sites for 15min at 20^0 prior to the addition of 
32P labelled double stranded oligonucleotides. 3]xl of dye (50% 
glycerol, 150mM NaCl, 25mM Hepes, 5mM MgCh, 20mM DTT,
0.01% NP40 and 0.05% bromophenol blue) was added to each assay 
mixture prior to loading onto a 6% polyacrylamide gel (55:1, 
acrylamide:N-N'-methylene-bis-acrylamide) and 50mM Tris borate, 
0.5mM EDTA, pH8.3 which was polymerised by addition of 0.6% (v/v) 
of 25% APS and 0.06% (v/v) of TEMED (Kodak). Gels were run at 200 
volts for 45-60 min in 50mM Tris borate, 0.5mM EDTA, pH8.3, fixed in 
10% acetic acid for 10 min, dried and exposed to X-ray film at -TO^C 
with an intensifying screen. Alternatively each NFI-DNA complex was 
cut out of the dried gel, submerged in 15ml of scintillation solution 
(Ecoscint A, National Diagnostics) and its radioactivity determined by a 
SL 30 Liquid Scintillation Spectrometer (Intertechniques).
11. Purification of NFI from S.frugiperda cells Infected with 
recombinant baculovims
One litre of S.frugiperda cells were infected at 2pfu/ceU with 
recombinant baculovims containing either NFIfl  or NFId b d  cDNA  
(Bosher et al., 1991). Infected cells were incubated for 72 hours at 280C 
and were then collected by centrifugation. The cells were washed once 
and resuspended in 5ml of a lysis buffer containing 25mM Hepes-NaOH 
(pH8.0), ImM ethylene-diamine tetra-acetic acid sodium salt (EDTA), 
2mM DTT, 0.4M NaCl, ImM benzamidine, ImM PMSF, ImM SMBS,
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0.5% NP40 and lOjig/ml antipain, pepstatin and leupeptin. This was left 
on ice for 10 min and the cells were further dismpted with 10 strokes in 
a Dounce homogeniser using a type B pestle. After a further 20 min on 
ice it was centrifuged at 45000g for 30 min at 40C. The supematent was 
diluted 1 in 2 with column buffer (25mM Hepes-NaOH (pH8.0), ImM 
DTT, 10% (v/v) glycerol, 2mM SMBS, ImM PMSF and lOpg/ml 
antipain, pepstatin and leupeptin) and clarified by centrifugation at 
45(XX)g for 15 min at 40C. To purify the NFI the clarified extract was 
applied directly to a column of Bio-Rex (Bio-Rad) equilibrated in 
column buffer containing 0.2M NaCl. Unbound proteins were removed 
by washing the column with two bed volumes of column buffer 
containing 0.2M NaCl. Bound proteins were eluted using 1ml aliquots 
of column buffer containing an increasing concentration of NaCl from 
0.25M to l.OM (increasing in 0.05M steps). The fractions were 
collected and their protein concentration determined by the method of 
Bradford (1976). The NFI DNA binding activity of these fractions was 
ascertained by gel electrophoresis DNA binding assays and scintillation 
counting of the NFI-DNA complex formed.
The fractions found to contain active NFI were pooled and diluted 
with column buffer to bring the NaCl concentration down to 0.25M.
6|Lig of poly(dl-dC) was added per mg of protein and then it was applied 
to a pre-equilibrated column containing the immobilised NFI-binding 
site linked via a 5'-amino link (Applied Biosystems) to CNBr-activated 
Sepharose (Pharmacia) as described (Clark et aL, 1990). Unbound 
proteins were removed by washing the column extensively with column 
volumes of column buffer. The bound NFI was eluted from the column 
in the same way as for the Bio-Rex column and the fractions tested for 
the presence of NFI as before.
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12. Radiolabelling of DNA fragments
A plasmid pHRI, obtained from R. T. Hay, (Hay, 1985) that 
contains the 103bp Ad2 ITR was cut with EcoRI and Pst I to excise the 
Ad2 ITR which was then ^^P end labelled using the Klenow fragment of 
E.coli DNA polymerase (Amersham). Ijig of the cut plasmid was 
incubated with 20pCi[a-^^P]dATP and unlabelled dGTP, dCTP and 
dTTP to final concentrations of lOOjiM in a buffer containing 50mM 
Tris (pH7.8), 5mM MgCh, ImM DTT and 100|ig/ml (w/v) bovine 
serum albumin (BSA) with 10 units of Klenow for 15 min at 20^0.
Then unlabelled dATP was added to a final concentration of lOOjiM for 
a further 15 min at 20^0. The reaction was stopped by addition of 1/5 
final volume of 50% glycerol, lOOmM EDTA and 0.05% bromophenol 
blue. Unincorporated dNTPS were separated from the labelled fragment 
by gel electrophoresis in an 8% polyacrylamide gel (29:1, acrylamide:N- 
N'-methylene-bis-acrylamide) containing lOOmM Tris borate, ImM 
EDTA, p H8.3 and was polmerised by addition of 0.6% (v/v) of 25% 
APS and 0.06% (v/v) of TEMED (Kodak). Gels were run at 200 volts 
for 45-60 min in lOOmM Tris borate, ImM EDTA, pH8.3. The band 
containing the labelled DNA fragment was located by autoradiography, 
excised from the gel and the DNA electroeluted.
13. DNase I footprinting
Labelled DNA (1.5ng) was incubated with varying amounts of 
NFIf l , NFId b d  and DBP in a final volume of 50jil containing 25mM 
Hepes-NaOH pH8.0, 5mM MgCb, 20mM DTT, 150mM NaCl, 0.01% 
N P40,0.5pg BSA and lOOng poly(dA.dT) and poly(dG.dC) for 60 min 
at 20^C. 0.25 units of DNase I (Amersham) was added and the 
incubation allowed to proceed for 60 seconds at 20^C and the reaction 
stopped by the addition of 200|xl of 0.3M NaOAc, 20mM EDTA and
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lOOfXg/ml tRNA. DNA was isolated by organic extraction followed by 
ethanol precipitation and resuspended in deionised formamide 
containing 2mM EDTA, 20mM NaOH, 0.05% bromophenol blue and 
0.05% xylene cyanole. The samples were mn on an 8% polyaciylamide 
gel (20:1, acrylamide :N-N'-methylene-bis-acrylamide) and containing 
lOOmM Tris borate,ImM EDTA, pH8.3,46% urea and polymerised by 
addition of 1/200 volume of 25% APS and TEMED. Gels were mn in 
l(X)mM Tris borate, ImM EDTA, pH8.3 at 2000 volts at 50®C until the 
leading dye front was approximately 1 inch from the bottom. The gels 
were dried and exposed to X-ray film at -70^0 in the presence of an 
intesifying screen.
14. Expression and radiolabelling of replication proteins in 
S.frugiperda cells infected with recombinant baculovims.
S.frugiperda cells were grown as monolayers in 90mm diameter 
dishes and infected with lOpfu/cell with the appropriate recombinant 
baculovims. After 48 hours at 28°C the cells were collected by 
centrifugation , washed once in PBS and resuspended in 1ml of 
methionine-free TCI00 (GIBCO) containing 500pCi of [35S] 
methionine (NEG-072 EXPRES^^gSSg^ Du Pont). Incubation was 
continued at 28^C for a further 3 hours. Cells were again collected by 
centrifugation, washed once with PBS, resuspended in lOOjxl of 0.4M 
NaCl, 25mM Hepes-NaOH pH8.0, ImM DTT, 0.5mM MgClz, 2mM 
SMBS, 0.5% NP40 and 10% glycerol and incubated on ice for 30 min. 
The cell debris was collected by centrifugation at 120(X)g for Imin and 
the supematent was diluted to a final NaCl concentration of 50mM and 
clarified by centrifugation at l(X),0(X)g for 30 min at 4^C.
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15. Affinity chromatography
Six 50pl columns containing either BSA or NFId b d  coupled to 
CNBr-activated Sepharose 4B were prepared and equilibrated with 
50mM NaCl, 25mM Hepes-NaOH pH8.0, ImM DTT, 0.5mM MgCh, 
2mM SMBS, 0.05% NP40 and 10% glycerol. The columns were 
saturated with an unlabelled extract of S.frugiperda cells infected with 
wild type baculovims and unbound proteins were washed away with the 
above buffer. Labelled extracts from S.frugiperda cells infected with 
recombinant baculovims expressing either pol, pTP or a mixture of both 
vimses were loaded onto NFId b d  and BSA columns and unbound 
proteins were washed away with the above buffer. Bound proteins were 
eluted with 50jil aliquots of 200mM NaCl, 25mM Hepes-NaOH pH8,0, 
ImM DTT, 0.5mM MgCh, 2mM SMBS, 0.05% NP40 and 10% 
glycerol and then analysed by SDS-polyacylamide gel electrophoresis 
and fluorography.
16. Analysis of SDS-PAGE gels using fluorography
The SDS-PAGE gels were fixed in 10% acetic acid, 20% 
methanol for 10 min and then carefully placed in a sealed box and 
washed twice in DMSG for 30 min each time on a gentle rocker. The 
DMSO was replaced with 22% PPG (w/v) dissolved in DMSG and 
rocked gently for 2 hours. The PPG/DMSG solution was removed and 
tap water was mn onto the gel for 30 min. The gel was then dried at 
60^C and exposed to X-ray film at -70^C.
17. Western blot analysis
Proteins were transferred from SDS-PAGE gels to nitrocellulose 
(soaked in 20% methanol, 0.02M Tris) by applying a current of 60mA 
for 60 min. The nitrocellulose was blocked by incubating with 10%
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(w/v) non-fat powdered milk (Marvel) in PBS for 60 min at 20oc. The 
nitrocellulose was briefly washed in 1% marvel/PBS and then incubated 
with antibody diluted in 1% marvel/PBS for 60 min at 200C. The 
nitrocellulose was washed thoroughly in several changes of PBS and 
then in 1% Marvel/PBS, The antibody-antigen complex was visualised 
using 125i-Protein A by incubating the nitrocellulose in l25i-Protein A 
diluted in 5ml of 1% Marvel/PBS for 60 min at 20oC. The 
nitrocellulose was washed in frequent changes of PBS until the 
background count was lowered to 2-5cps and then exposed to X-ray film 
at -70OC.
18. Immunoprécipitations
Cell extracts from cells labelled with [35S]-methionine (as 
described previously) were also used in immunoprécipitations. lOjil of 
the appropriate antisera was added to 200jii of extract and incubated at 
4 0 c  for 60 min with constant agitation. A 10% suspension of Protein A- 
Sepharose beads (150|li1, Sigma) was added and incubated at 4^C for 60 
min with constant agitation. The Protein A-Sepharose beads were 
collected by centrifugation and washed three times in 1ml of 25mM 
Hepes-NaOH pH8.0,5mM KCl, ImM DTT, 0.5mM MgCl, 0.5% NP40 
before being resuspended in 30|li1 of 30% (v/v) glycerol, 15% (v/v) 6- 
mercaptoethanol, 6%(w/v) SDS, 0.128M Tris-HCl (pH6.7) and 0.05% 
bromophenol blue. After being heated at 8 OOC for 10 min the beads 
were removed by centrifugation and the proteins were fractionated on a 
10% SDS-PAGE gel which was analysed by fluoragraphy.
19. Immunofluorescence
A549 cells were grown on circular glass coverslips to 
subconfluence and then infected with Ad2 or Ad4 at varying
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multiplicities of infection and for varying times post infection. Cells 
were carefully washed twice in PBS and then fixed in one of two ways:
i) for 10 min at RT in 5% (v/v) formaldehyde, 2% (w/v) sucrose in PBS 
followed by two washes in 1% normal donkey semm in PBS. The cells 
were permeabilised for 5 min at 20^C in 0.5% N P40,10% (w/v) 
sucrose, 1% normal donkey semm in PBS followed by two washes in 
1% normal donkey semm. When the cells were not used immediately 
they were stored in 1% normal donkey semm, 0.1% NaNg in PBS at 
4 0 c  after fixation but before permeabilisation.
ii) for 10 min at -200C in absolute methanol (-20^0  followed by two 
washes with 1% normal donkey semm in PBS. When the cells were not 
used immediately they were stored in the absolute methanol at -20®C.
The primary antibodies (either polyclonal or monoclonal) were 
appropriately diluted in 1% normal donkey semm in PBS and applied to 
the cells in a lOpl drop. They were either incubated for 60 min at 20®C 
or for 30 min at 31^C, The cells were then washed for 1 min in 1% 
normal donkey semm in PBS; for 2 min in 1% normal donkey serum, 
0.5% NP40 in PBS; for 10 min in 1% normal donkey semm in PBS and 
for 20 min in 1% normal donkey semm.
Sites of proteins indirectly labelled with rabbit polyclonal antisera 
were visualised using FITC-conjugated donkey anti-rabbit IgG (Jackson 
Immuno Research Laboratories Inc.) diluted 1/1(X) with 1% normal 
donkey semm in PBS. Sites of proteins indirectly labelled with mouse 
monoclonal antibodies were visualised using Texas Red-conjugated 
donkey anti-mouse IgG (Jackson Immuno Research Laboratories Inc.) 
diluted 1/100 with 1% normal donkey semm in PBS. These antibodies 
were applied to the cells in a lOjil drop and and incubated for 60 min at 
20^C or 30 min at 37®C. The cells were then washed for 1 min in 1% 
normal donkey semm in PBS; for 2 min in 1% normal donkey serum.
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0.5% NP40 in PBS; for 10 min in 1% normal donkey serum in PBS; for 
20 min in normal donkey serum in PBS and finally two lOmin washes in 
PBS.
The cells were mounted in a glycerol/PBS solution (Citifluor Ltd) 
and sealed using dental wax or nail varnish before they were viewed 
under a Nikon Microphot conventional immunofluorescence microscope 
or a laser scanning confocal microscope (Bio-Rad 500).
20. Bromodeoxyuridine labelling
After 24 hours of Ad2 infection A549 cells grown on coverslips 
were labelled with 5-bromodeoxyuridine (BrdU) for 15 min at 3 7 by 
replacing their media with prewarmed media that contained 40|iM 
BrdU, 5pM uridine, 0.4 |liM  5-fluorodeoxyuridine and 20mM Hepes- 
NaOH phS.O. Then the cells were washed in cold PBS and fixed with 
absolute methanol as described previously. The ceUs were removed 
from the methanol, washed twice in PBS and were either stained with 
the appropriate antibodies or were pretreated, prior to staining, for 30 
min with 22.5 units of Eco RI in 150)11 of buffer (React 3, BRL) 
followed by 45 units of exonuclease IE in 150|il of buffer (50mMTris- 
HCl, pH8.0,5mM MgCl2, ImM DTT) for 30 min.
Sites containing BrdU labelled DNA (Br-DNA) were indirectly 
labelled using lOjxl of undiluted monoclonal antibodies specific for 
bromodeoxyuridine (Becton Dickinson hnmunocytometry Systems ) for 
60 min at 20®C or 30min at 37^C. Then the cells were tieated as for 
standard immunofluorescence.
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21. Synchronisation of cells at the G l/S boundary of the cell cycle
A549 cells were grown to 80% confluence in 90mm dishes under 
normal growth conditions and then the media was replaced with G- 
MEM supplemented with 10% newborn calf serum containing Ijig/ml of 
aphidicolin (Sigma). The aphidicolin block on DNA synthesis was 
removed after 18 hours at 37^C by washing the cells four times with 
normal growth media.
The effectiveness of the aphidicolin block and the cell's passage 
through the cell cycle was monitored using the CycleTEST (Becton 
Dickinson) and a FACScan flow cytometer.
21. CycleTEST and FACScan Flow Cytometry
At various times (0, 2 ,4 ,6 , 8,10 and 12 hours) after the 
aphidicolin block was removed the cells were collected by centrifugation 
for 15 min at 300g at RT and washed twice with citrate buffer (Becton 
Dickinson). Then they were collected in a final volume of 5(X)|il of 
citrate buffer. If the cells were not to be stained immediately then they 
were snap frozen in a mixture of dry ice and 99% ethanol and stored at 
-70OC.
Before staining frozen samples were thawed rapidly in a 37^0 
waterbath without the sample itself reaching that temperature. Then 
0.9ml of trypsin buffer (Solution A, Becton Dickinson) was added to a 
200|il aliquot of the cell suspension and was gently inverted 
continuously for 10 min at 20^0. 0.75ml of trypsin inhibitor and RNase 
buffer (Solution B, Becton Dickinson) was added and gently inverted 
continuously for a further 10 min at 20^0. 0.75ml of ice cold propidium 
iodide stain (Solution C, Becton Dickinson) was added for 10 min at 
20^C and kept protected from the light. This was transferred to Falcon
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tubes and kept on ice and protected from light until flow cytometric 
analysis (no longer than three hours after addition of Solution C).
22. Cell encapsulation and lysis
An aliquot (2x10^ cells) of uninfected and Ad2 infected (for 12 
hours) A549 cells were encapsulated in agarose beads as follows. The 
cells were collected by centrifugation, washed once in PBS and then 
resuspended in 1ml of PBS. Each aliquot was transferred to a round 
bottomed flask in a 33^0 waterbath and 250jLil of prewarmed 2.5% 
agarose was added and gently mixed. 10ml of parafin was added and 
the flasks sealed and put on a flask shaker for 10-15 sec and then 
immediately plunged into ice. 35ml of ice cold PBS was added and then 
the mixtures were transferred to 50ml tubes and centrifuged at 2K for 3 
min to collect the beads. The interface was disturbed and then they were 
centrifuged again. The parafin was aspirated down to 20ml remaining 
volume and 10ml was transferred to a 10ml sterilin tube and centrifuged 
as before. The supematent was discarded and the remaining beads were 
added and centrifuged. The beads were washed with PBS and 
resuspended in 10ml of G-MEM supplemented with 1% newborn calf 
serum and incubated at 33®C for 30 min.
The beads were collected by centrifugation and washed with PBS 
three times. 10ml of Streptolysin O (40 units, Wellcome) was added for 
30 min on ice. The beads were washed once in ice cold PBS and then 
resuspended in prewarmed 'physiological' buffer (PB) for 3 min at 33^0. 
PB (pH7.4) contains 22mM Na+, 130mM K+, ImM Mg^+, <0.3jiM free 
Ca^+, 3ImM CP, lOOmM acetate, l l m M  phosphate, ImM ATP, ImM 
DTT and 0.2mM PMSF. The beads were chilled on ice and then washed 
once with PB buffer and pelleted. The beads containing uninfected and
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Ad2 infected cells were each aliquoted into four lots of 250|xl and kept 
on ice.
24. Labelling sites of transcription
The encapsulated beads were pre-incubated at 33<^C for 2 min and 
prewarmed transcription mix (lOX concentration) was added to give 
final concentrations of 2mM ATP, 2mM MgCli, lOOunits/ml RNase 
inhibitor (Pharmacia), 50pM CTP, GTP (Pharmacia) and Br-UTP 
(Sigma). Reactions were incubated at 33®C for 15 min and then beads 
were washed twice in ice cold PB containing 20units/ml RNase 
inhibitor.
25. Labelling sites of replication
The encapsulated beads were pre-incubated at 33®C for 2 min and 
prewarmed replication mix (lOX concentration) was added to give final 
concentrations of 2mM ATP, 2mM MgCli, lOOjiM dATP, dCTP, dGTP 
(Pharmacia) and Biotin-16-dUTP (Boehringer) and 50pM CTP, GTP 
and UTP (Pharmacia). Reactions were incubated at 33®C for 15 min 
and then the beads were washed twice in ice cold PB.
26. Labelling sites of transcription and replication
The encapsulated beads were pre-incubated at 33®C for 2 min and 
pre warmed replication and transcription mix (lOX concentration) was 
added to give final concentrations of 2mM ATP, 2mM MgCl2, 
lOOunits/ml RNase inhibitor, lOOpM dATP, dCTP, dGTP and Biotin- 
16-dUTP and 50pM CTP, GTP and Br-UTP. Reactions were incubated 
at 33®C for 15 min and then the beads were washed twice in ice cold PB 
containing 20units/ml RNase inhibitor.
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27. Visualisation of transcription and replication sites
The pelleted beads were immediately permeabilised by incubation 
in 0.2% Triton X-100 in PB (20units/ml Rnase inhibitor was in aU 
buffers and washes used for the labelled transcription sites) for 15 min 
on ice. The beads were fixed for 15 min on ice in 0.3% 
paraformaldehyde in PB and then washed three times with 0.05% Tween 
in PBS.
Sites containing Br-UTP labelled RNA (Br-RNA) were indirectly 
labelled using lOOpl of a 1/20 dilution of monoclonal antibodies specific 
for bromodeoxyuridine (Boehringer) for 4 hours on ice. The beads were 
washed twice with 0.05% Tween in PBS followed by a 15 min wash 
with 0.05% tween, 0.05% BSA in PBS. Then they were labelled using 
lOOfxl of a 1/500 dilution of Texas Red-conjugated sheep anti-mouse Ig 
(Amersham) overnight at 4®C.
Sites containing Biotin-16-dUTP labelled DNA (Biotin-DNA) 
were directly labelled using l(X)pl of a 1/20,000 dilution of Streptavidin- 
FITC (Sigma) overnight at 4®C.
The beads were washed twice with 0.05% Tween in PBS followed 
by two washes in PBS. The beads were mounted under coverslips in 
Mowiol 4-88 (Hoechst) containing O.lpg/ml DAPI (Boehringer) and 
2.5% DABCO (l,4-diazobicyclo-[2.2.2]-octane; Sigma). Photographs 
were taken using a Zeiss Axiophot microscope (1(X)X oil-immersion 
objective).
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CHAPTER ONE
Direct and indirect interactions of NFI with Ad2 replication proteins
Expression of replication proteins in insect cells
One difficulty in detecting specific protein-protein interactions in 
adenovirus infected cells is that many of the proteins may already exist 
in specific protein complexes thereby making it hard to determine their 
individual properties. The use of recombinant baculoviruses that 
express the various replication proteins addresses this problem and also 
provides larger quantities of protein for purification and characterisation.
Spodoptera frugiperda cells were infected with 2 p.f.u./cell of the 
appropriate recombinant baculoviruses and cell extracts were prepared 
after 72 hours, aliquots of which were analysed by SDS-PAGE 
followed by staining with Coomassie blue. Proteins corresponding to 
the 140kD pol, 80kD pTP and the 35kD NFId b d  are detected in 
substantial levels (fig. 6).
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FIGURE 6. SDS-PAGE of extracts from uninfected 5 . cells (lane 4) or cells infected with wild-type baculovirus expressing polyhedrin (phd, lane 3), or 
recombinant baculoviruses expressing pTP (lanel), pol (lane 2) or NFIdbd (lane 5).
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Purification of NFIfl and NFIdbd
The proteins of the NFI family have a conserved N-terminal 
domain which is required for DMA binding plus additional sequences 
which are involved in transcriptional regulation (Mermod et al., 1989). 
To determine the role of the different NFI domains in Ad2 DNA 
replication the CTFl cDNA (full length protein) and the DNA-binding 
domain of CTFl were inserted into recombinant baculoviruses (Bosher 
et al., 1991). Both N F Ifl and NFIdbd were individually purified from 
cell extiacts of S. frugiperda cells that had been infected with 
2p.f.u./cell of baculoviruses containing either N F Ifl or NFIdbd cDNA 
for 72 hours. They were purified by a combination of ion-exchange 
chromatography and DNA affinity chromatography.
Ion-exchange chromatography involves the separation of proteins 
on the basis of their net charge. Positively charged proteins bind to the 
Bio-Rex ion-exchange column and are then eluted with sodium chloride. 
Sodium ions compete with positively charged groups on the protein for 
binding to the column. Proteins with a lower density of net positive 
charge wiU be eluted first followed by those having a higher charge 
density. The CTFl DNA binding domain has a net positive charge due 
to a number of lysine and arginine residues which cluster on one side of 
the a-helical protein structure to form a novel a-helical sequence motif 
which may contact backbone phosphates of the DNA (Meisteremst et 
al., 1989).
To determine the optimum NaCl concentration required to elute NFIfl 
and NFIdbd from the Bio-Rex column 0.05M stepwise increases in the 
NaCl concentration of the column buffer (25mM Hepes-NaOH pH8.0, 
ImM DTT, 10% (v/v) glycerol, 2mM SMBS, ImM PMSF and 10|Xg/ml 
antipain, pepstatin and leupeptin) were initially used. The eluted 
fractions that contained NFI were identified using gel electrophoresis
DNA-binding assays with the 32p-DNA-NFI complex being measured 
by scintillation counting (fig. 7).
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FIGURE 7. NFI DNA-binding activities of fractions eluted from the Bio-Rex 
column were determined by gel electrophoresis DNA-binding assays where the NFI- 
DNA complex was measured using scintillation counting.
As expected the peak of NFIdbd eluting from the column occured at a 
higher NaCl concentration than that of NFIfl  because NFIdbd  has a 
higher net positive charge due to the cluster of basic residues which 
make up the 'lysine helix'. Figure 7 shows that NFIfl  should be eluted 
with 0.6M NaCl whereas NFIdbd should be eluted with 0.7M NaCl.
DNA affinity chromatography makes use of the specific DNA 
binding property of NFI by using a column containing the NFI-binding 
site linked via a 5'-amino link to CNBr-activated Sepharose. To 
determine the optimum NaCl concentration required to elute NFIf l  and 
NFId b d  from the affinity column 0.05M stepwise increases in the NaCl 
concentration of the column buffer were initially used. The eluted 
fractions that contained NFI were identified using gel electrophoresis
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DNA-binding assays with the 32p.DNA-NFT complex being measured 
by scintillation counting (fig. 8).
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FIGURE 8. NFI DNA-binding activities of fractions eluted from the DNA affinity column which contains a double stranded synthetic oligonucleotide representing 
positions 18 to 41 from the Ad2 origin of DNA replication.
The peak of NFIfl elution occured at 0.75M NaCl whereas the 
peak elution of NFIdbd  occured at 0.8M NaCl which again could be a 
reflection of the more basic nature of the DNA binding domain and the 
negatively charged DNA. In future purifications both species were 
eluted with l.OM NaCl, having been loaded on at 0.25M NaCl, with 
washes being carried out with 0.4M NaCl in column buffer.
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FIGURE 9. SDS-PAGE followed by Coomassie blue staining on NFIfl and 
NFIdbd  samples purified by ion exchange chromatography and DNA affinity 
chromatography. Lane 1 contains molecular weight markers (200,97.4, 68,43, 29, 
18.4 and 14.3kD, GIBCO BRL), lane 2 DBF, lane 3 NFIfl and lane 4 N H dbd.
N F Ifl is purified predominanty as a single species of 62kD whereas 
NFIdbd elutes from the column as two species, one of which appears to 
be generated from the other by proteolysis. It was usual to purify 1- 
1.5mg of NFI from 1 litre of infected S. frugiperda cells.
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Stimulation of binding of NFI to DNA by Ad2 DBF
Ad2 DBF can increase the affinity of NFI for its recognition site 
in the Ad2 origin of DNA replication (Cleat and Hay, 1989; Stuiver and 
van der Vliet, 1990). To determine whether the fhll-length protein or 
only the DNA-binding domain of NFI is required for this, DNase I 
footprinting analysis was carried out. DNase I footprinting involves 
incubating a DNA fragment (radioactively labelled at one end) with a 
possible DNA binding protein and then digesting the DNA with a 
limited amount of DNase I so that on average there is one cut per DNA 
molecule. In the presence of a sequence specific DNA binding protein 
such as NFI the DNA bound by the protein is protected from DNase I 
digestion thereby resulting in a footprint (protected region) in the DNA 
cleavage pattern.
A 3'-labelled DNA fragment containing the NFI binding site from 
the Ad2 replication origin was incubated with increasing amounts of 
purified NFIfl  or NFIdbd  in the absence of DBF for 60 min at 2Q0C 
and then subjected to digestion with DNase I. The fuU length protein 
and the DNA binding domain appeared to bind to the Ad2 origin of 
DNA replication with similar affinity and indistinguishable patterns of 
DNase I protection (fig lOA). Following on from this NFIfl  and 
NFIdbd  were used in further experiments at concentrations giving only 
partial protection of the binding site from cleavage with DNase I. 
Addition of increasing concentrations of DBF to NFIfl  and NFIdbd 
resulted in an increase in NFI site occupancy in each case (fig lOB) 
indicating that DBF only required the DNA binding domain of NFI to 
increase its affinity for its recognition site.
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FIGURE 10. The Eco Rl-Pst I fragment from pHRI containing the Ad2 origin of 
DNA replication was 3'end-labelled at the EcoRl site and incubated with various 
concentrations of NFI and DBF prior to DNase I digestion.
A. DNase I cleavage pattern produced in the absence of NFI and DBF (lane 0), and 
increasing concentrations of OTIfl (lane l,1.6ng; lane 2 ,4.8ng; lane 3 , 16ng) or 
NFIdbd (lanel, 1.5ng; lane 2, 5ng; lane 3, 15ng).
B. Labelled DNA was incubated alone (lanes 0) or in the presence of N F Ifl (0.8ng) or NFIdbd (0.6ng) and increasing concentrations of DBF (lanes 1, lOng; lanes 2, 20ng; lanes 3, lOOng; lanes 4, 2(X)ng; lanes 5, 250ng) prior to DNase I digestion.
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Interaction of the DNA polymerase-preterminal protein 
heterodimer with NFIdbd
To identify proteins that interact with NFId b d  six SOjiil columns 
containing either NFId b d  or BSA coupled to CNBr-activated Sepharose 
4B were prepared and equilibriated with 50mM NaCl, 25mM Hepes- 
NaOH pH8.0, ImM DTT, 0,5mM MgCh, 2mM SMBS, 0.05% NP40 
and 10% glycerol. Because of the charged nature of NFId b d  proteins 
win bind to it non-specifically so the columns were saturated with 
unlabelled extracts of S. frugiperda cells infected with wild type 
baculovims to block these non-specific binding sites. Insect cells were 
infected with recombinant baculoviruses expressing either pol or pTP or 
a mixture of both. After 72 hours the proteins were labeled in vivo with 
[35S] methionine and then whole cell extracts were prepared. Extracts 
were loaded onto the columns in a buffer containing 50mM NaCl and 
unbound protein removed by extensive washing with 25mM Hepes- 
NaOH pH7.5, ImM DTT, 0.5mM MgClz, 50mM NaCl, 2mM SMBS, 
0.05% NP40 and 10% glycerol. Bound proteins were eluted by 
increasing the NaCl concentration to 200mM and analysed by SDS- 
PAGE and fluorography. Even in the presence of saturating amounts of 
unlabelled extract from wild-type baculovirus infected ceUs the bulk of 
the Ad2 DNA polymerase was bound to the NFId b d  column and eluted 
by 200mM NaCl (fig. 1 IB and 1 ID). In contrast no specific binding of 
pTP to NFId b d  was detected from extracts that did not contain pol (fig. 
11C). However pTP was eluted from NFId b d  when pol was also 
present in the extracts (fig. 1 IB). Neither pol or pTP bound to the BSA 
(fig. 11 A). Since pTP and pol exists as a heterodimer in adenovirus 
infected cells this demonstrates that pTP alone can not bind to NFI but 
as part of the heterodimer can do so via pol which does interact with 
NFI.
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FIGURE 11. S. frugiperda cells infected with baculovirus expressing either pTP, 
pol or both were labelled with [^^S] methionine and cell extracts were loaded onto 
small (50pl) columns of NFIoBD-Sepharose or BS A-Sepharose that had been 
previously saturated with an extract from S. frugiperda cells infected with wild-type 
baculovirus. Columns were washed and eluted and the protein fractions were analysed by SDS-PAGE and fluorography.
A. Neither pol or pTP were eluted from the BSA columns.
B. Both pol and pTP were eluted from the NFIdbd column.
C. pTP was not eluted from the NFIdbd column when pol was absent
D. pol was eluted from the NFIdbd column when pTP was absent.
SUPPLEMENT 
Purification of NFId b d  and NFIfl
The object of purifying both N F Ifl and NFIdbd was to obtain 
enough protein, as quickly as possible, to allow the production of 
polyclonal antisera in rabbits as well as to carry out some experiments. 
The protocol settled upon routinely resulted in l-1.5mg of purified NFI 
per litre of Spodoptera frugiperda cells infected with the appropriate 
recombinant baculovirus.
Figure 7 demonstrates that NFIfl  is eluted from the Bio-Rex 
column with 0.6M NaCl whereas NFIdbd  requires 0.7M NaCl. As a 
result these were the NaCl concentrations used in all subsequent 
purifications. Figure 8 shows a similar elution profile from the DNA 
affinity column where both NFIfl and NFIdbd  both require a higher 
NaCl. Although the NaCl concentration does not go high enough to 
elute all of the protein it was felt that there was enough information 
available to ascertain that both NFIfl  and NFIdbd  could be eluted with 
IM NaCl. In subsequent purifications the affinity column was washed 
with 0.4M NaCl after NFI was bound to it and then it was eluted with 
IM NaCl.
Figure 9 illustrates the good level of purity obtained using the 
finalised purification protocol. The doublet seen in purified NFIdbd 
seems to be the result of proteolysis. Supporting evidence of this comes 
from the knowledge that the DNA binding activity of NFI is present in a 
highly protease resistant domain (Cleat and Hay, 1989b) and that the 
slower migrating band can be converted into the faster one by limited 
proteolysis in vitro. A  possible alternative explanation for the doublet 
was that it could represent two phosphorylation states of NFI. However 
this seems unlikely since radioactive labelling of the potential
phosphorylation sites of NFIfl and NFIdbd  indicated that they exist 
outside of the DNA binding domain.
Stimulation of binding of NFI to DNA by Ad2 DBF
The DNase I footprinting in figure 10 demonstrates that Ad2 
DBF stimulates the binding of NFI to its recognition site in the Ad2 
origin of DNA replication. This experiment could have been greatly 
improved had the relative amounts of the various proteins been adjusted 
more. In both footprints the concentrations of NFIf l , NFIdbd  and 
DBF should have ranged significantly lower to obtain the gradual 
emergence of the protection pattern rather than the all or nothing result 
obtained.
Interaction of the DNA polymerase-preterminal protein 
heterodimer with NFId b d
Figure 11 clearly demonstrates that the N-terminal 35kD of NFI 
is able to interact with the pol-pTF heterodimer via pol. BSA was used 
in the control columns because it is cheap and readily available. Any 
doubt over whether this provides the experiment with an acceptable 
control is unnecessary because the behaviour of pTF presents itself as an 
inbuilt control. Fol binds to the NFlDBD-Sepharose column with or 
without pTF whereas pTF requires the presence of pol before it is able 
to bind. This indicates that when the pol-pTF heterodimer interacts 
with the DNA binding domain of NFI it does so via pol. This could also 
have been shown by binding pol to an NFlDBD-Sepharose column and 
then adding pTF to see if it then bound.
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CHAPTER 2
NFI is specifically targeted to discrete subnuclear sites in Ad2 
infected cells.
NFI has a crucial role to play in Ad2 DNA synthesis and is 
incorporated into nucleoprotein complexes containing the Ad2 origin of 
DNA replication, the pTP-pol heterodimer and DBF.
Fate of NFI after Adenovirus type 2 infection
Since NFI is required for efficient Ad2 DNA replication its fate in 
cells after Ad2 infection was examined. NFI levels were determined 
using a polyclonal antisera raised against NFId b d  purified from insect 
cells infected with the NFId b d  expressing recombinant baculovirus.
The specificity of this antibody for NFIfl  was tested using 
immunoprécipitation and western blot analysis. Insect cells infected 
with wild type baculovirus or the recombinant vims expressing NFIfl  
were labelled with [^5S] methionine and extracts immunoprecipitated 
with the NFIdbd antisera. The antibody efficiently immunoprecipitated 
the 62,000 molecular weight NFIfl protein from extracts of insect cells 
infected with the recombinant vector, but does not recognise proteins 
from the cells infected with a baculovirus containing the Ad2 pol gene 
(fig. 12A).
A549 cells were infected (lOp.f.u./cell) with Ad2 and harvested at 
various times after infection for Western blot analysis. In infected cells 
the NFI family of proteins is apparent as a multiple series of 
immunoreactive species ranging in size from 55-62,000 molecular 
weight. Infection of these cells with Ad2 appears to have little effect on 
the overall levels of NFI protein (figure 12B). To ensure that cells had
77
B
a-NFI AcNPV AcNPV NH Ex IP Ex IP
a NFI 
AcNPV AcNPVNFI DBD Nn 48
a-NFI time p.l. (hours)36 24 12
DBP
a-DBP
Time p.i. (hours) 
0 12 24 36
I I
D
time p.L (hours) 
0 12 24 36 48 Iü j
FIGURE 12. Fate of NFI after Ad2 infection of A549 cells.
A. Extracts from S. frugiperda cells infected with recombinant baculovirus 
expressing NFI (ACNPV NFI) or Ad2 DNA polymerase (AcNPV) were 
immunoprecipitated with polyclonal antibodies raised againstNFIoBD (a-NFI). Whole-cell extracts (Ex) or immunoprecipitated proteins (IP) were resolved by 
electrophoresis in an 8% polyacrylamide gel and labelled proteins were detected by fluorography.
Extracts were prepared from S. frugiperda cells infected with a recombinant 
baculovirus expressing NFIdbd  or the NFIfl (NFI) and from A549 cells infected for the indicated times with Ad2 (p.i., postinfection).
B. Extracts were fractionated by SDS-PAGE and NFI proteins were detected with anti-NFI (a-NFI) primary antibodies and alkaline phosphatase-conjugated secondary 
antibodies by using BCIP-NBT colour development.
C. Extracts were fractionated by SDS-PAGE and DBP was detected with anti-DBP 
(a-DBP) primary antibodies followed by ^^Sj.protein A. Purified DBP was analysed in parallel.
D. Extracts were used in gel electrophoresis DNA binding assays to investigate the 
NFI DNA-binding activities present at various times post infection. Unlabelled 
oligonucleotide competitors contained binding sites for NFI, NFIII or NF-kB and 
were added in 100-fold molar excess.
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been successfully infected samples of the same extracts were tested for 
the presence of the adenovirus coded DBP. Western blot analysis with a 
DBP specific antiserum indicated that, as expected, DBP levels increase 
throughout the course of the infection (figure 12C).
While it is possible that the level of NFI proteins does not change 
during the course of Ad2 infection it is conceivable that the activity of 
the protein is modified. Gel electrophoresis DNA binding assays were 
carried out on samples of the same extracts used previously to 
investigate whether the DNA binding activity of NFI varied as Ad2 
infection proceeds. In uninfected and Ad2 infected cells a typically 
heterogeneous series of DNA-protein complexes was formed between 
NFI proteins and their DNA recognition site with no apparent variation 
in NFIs ability to bind DNA. Competition experiments demonstrated 
the specificity of the interaction with addition of unlabelled 
oligonucleotides containing the NFI recognition site in the binding 
reaction precludeding formation of the DNA-protein complex, whereas 
addition of oligonucleotides containing unrelated binding sites had no 
effect on formation of the DNA-protein complexes (figure 12D). Thus 
the ability of NFI proteins to bind to a double stranded oligonucleotide 
containing the NFI recognition site present in the Ad2 origin of DNA 
replication did not change after Ad2 infection (figure 12D).
The nuclear distribution of NFI is altered after adenovirus type 2 
infection.
Although the level of NFI proteins or NFI DNA binding activity 
did not appear to change after adenovims infection, it is entirely possible 
that other properties of the protein are altered. It has long been known 
that adenovirus early proteins or P-antigens are not evenly distributed 
throughout the nucleus but are localised in discrete nuclear sites
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(Hayashi and Russell, 1968). Viral DNA and replication proteins are 
contained in these foci, which are thought to be the sites of viral DNA 
synthesis. In view of the involvement of NFI in Ad2 DNA replication 
the subcellular location of NFI, before and after infection with Ad2, was 
determined by immunofluorescence using the polyclonal antiserum 
raised against NFIdbd that had been antigen affinity purified. A 
polyclonal antiserum specific for the virus coded DBP was used in 
parallel to identify the presumed foci of viral DNA replication.
Uninfected cells or cells infected at less than 1 p.f.u. per cell with 
Ad2 were fixed in formaldehyde, permeabilised with detergent and 
incubated with either the NFI or DBP specific rabbit antiserum. An 
FITC conjugated second antibody was used to permit visualisation of the 
antibody locations by fluorescence microscopy. Uninfected cells 
displayed no cross reaction with the DBP antibody (figure 13A), but in 
infected cells the DBP antibody revealed a strikingly punctate 
localisation that is characteristic of the protein (figure 13C). In 
uninfected cells NFI was localised to the nucleus with a slightly granular 
distribution (figure 13B), but its distribution in infected cells was 
dramatically different, taking on a punctate appearance (figure 13D) that 
was reminiscent of that observed with DBP (figure 13C).
Colocalisation of NFI and the adenovirus DBP.
To determine if NFI and DBP are localised to identical sites in 
Ad2 infected cells, antibodies to DBP and NFI were applied to the same 
cells and then visualised by double fluorescence. A mouse monoclonal 
antibody directed against an epitope present on the Ad2 DBP (Reich et 
a i,  1983) was used in conjunction with a Texas Red conjugated goat 
anti-mouse immunoglobulin whereas an FITC conjugated goat anti­
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rabbit immunoglobulin was used to localise the rabbit antibodies bound 
to NFI.
FIGURE 13. Cellular distribution of NFI (B and D) and DBP (A and C) before (A 
and B) and after (C and D) infection for 24 hours with Ad2.
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Figure 14 clearly shows that NFI and DBP are colocalised to the same 
sites within Ad2  infected cells.
F ig u r e  14. Colocalisation of DBP (A) and NFI (B) in A549 cells infected with 
Ad2 and examined by conventional fluorescent microscopy.
To more precisely demonstrate the identity of the sites of NFI and 
DBP localisation Ad2 infected cells were examined by laser scanning 
confocal microscopy. Shown in figure 15 is the fluorescence emmision 
from a 0.5mm thick optical section taken through Ad2 infected A549 
cells treated with NFI and DBP antibodies as described previously. It is 
evident from this optical section that NFI (fig. 15H) and DBP (fig. 15G) 
are indeed present at the same subcellular locations in infected cells thus 
confirming the results of the conventional microscopy. Confocal 
microscopy allows the two separate NFI and DBP images to be merged 
to demonstrate absolutely that they are colocalised (fig 15M). Control 
experiments where one of the primary antibodies had been omitted 
indicated that, under the conditions employed in these experiments, 
crossover in the FITC and Texas Red channels was negligible.
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FIGURE 15. Colocalisation of DBP (G) and NFI (H) in A549 cells 
infected with Ad2 and examined by laser scanning confocal microscopy. 
M. The image from G and H has been coloured and merged to 
demonstrate how precisely they colocalise.
Effect of various times post infection.
To investigate the point in the infectious cycle when DBP and 
NFI distribution is altered, cells were fixed at various times after 
infection and processed for microscopy as described previously. At a 
low multiplicity of infection (1 p.f.u./cell), 18 hours after infection DBP 
localisation takes one of two forms, being either punctate or evenly 
distributed (fig. 16A). In the cells where DBP is localised to discrete 
sites it is apparent that NFI is also concentrated in these sites (fig. 16B). 
As the infection proceeds the proportion of DBP in discrete sites
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increases, being initially present in a small number of large foci (fig. 
16C) and at later stages in a larger number of smaller foci (fig. 16E). 
This behaviour is also observed with NFI with the protein apparently 
being localised to the same discrete sites as DBP (fig.. 16D and 16F).
FIGURE 16. Effect of various times post infection on the distribution of DBP and 
NFI. A549 cells were infected at a low multiplicity of infection (Ip.f.u./cell) for 18 
hours (A and B), 24 hours (C and D) and 48 hours (E and F).
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Ad2 DBP is localised to sites of viral DNA replication.
To determine if the regions to which NFI and DBP are colocalised 
are sites of viral DNA replication Ad2 infected A549 cells were pulse 
labelled with the thymidine analogue 5-bromodeoxyuridine (BrdU). 
Newly synthesised DNA which incorporated BrdU can then be 
immunolocalised with a monoclonal antibody specific for BrdU, 
provided that the DNA has been rendered single stranded. In the 
procedures developed for the detection of newly synthesised cellular 
DNA (Fox et ah, 1991) single stranded DNA is generated by the 
combined action of Eco RI and exonuclease III. However, since 
adenovirus replicates by a strand displacement mechanism which 
generates single stranded DNA nuclease treatment of the cells is 
unnecessary. This difference therefore provides a convenient means of 
distinguishing between newly replicated cellular and viral DNA. Ad2 
DNA, but not cellular DNA, will be detected in the absence of nuclease 
treatment whereas both Ad2 and cellular DNA will be detected after 
nuclease pretreatment. A549 cells infected with Ad2 for 24 hours were 
pulse labelled for 15 minutes with BrdU and either pretreated with 
nuclease or processed directly. Ad2 DBP was detected with a rabbit 
polyclonal antibody (fig. 17A and 17C) whereas BrdU was detected with 
a mouse monoclonal antibody (fig. 17B and 17D). It is clear that the 
previously identified sites of DBP accumulation are also sites of BrdU 
incorporation (fig. 17; compare panels A with B and C with D). As 
these sites of BrdU incorporation are detected either with (fig. 17D) or 
without (fig. 17B) nuclease pretreatment this indicates that the areas of 
DBP accumulation are also sites of viral DNA replication. It is worth 
noting that the pattern of DBP fluorescence in nuclease treated cells is 
less weU defined than in untreated cells (fig. 17; compare panels A and
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C) and this may be a consequence of the nuclease treatment releasing 
genome bound DBP.
BQK
FIGURE 17. Colocalisation of DBP (A and C) and BrdU-labelled DNA 
(B and D) in A549 cells infected with Ad2, Panels A and B are 
immunofluorescence pictures of cells that were not treated with Eco RI- 
exonuclease HI, whereas panels C and D are of cells that were treated with 
Eco Rl-exonuclease HI.
NFI does not colocalise with DBP in adenovirus type 4 infected cells
While it is evident from figures 14 and 15 that Ad2 DBP and NFI 
are present in the same subnuclear sites it is not clear whether this is a 
specific targeting event or whether it is a non-specific consequence of 
structural rearrangements that take place in the nucleus after infection. 
To address this question we made use of adenovirus type 4 (Ad4) which 
replicates efficiently in A549 cells but which does not appear to require 
the involvement of NFI. The Ad4 origin of DNA replication lacks an 
NFI binding site and addition of purified NFI fails to stimulate Ad4
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DNA replication in vitro (Hay, 1985; Harris and Hay, 1988). A549 
cells were infected with Ad4 and the location of NFI and DBP 
determined by double immunofluorescence using rabbit antibodies 
specific for NFI and mouse antibodies specific for DBP. The mouse 
monoclonal antibody that recognises an epitope present on Ad2 DBP 
(Reich et a/., 1983) also recognises a similar epitope present on Ad4 
DBP (Temperley et a i, 1991). As in Ad2 infected cells, Ad4 DBP is 
localised to discrete sites within the nucleus (fig. 18A and 18C) but in 
contrast the distribution of NFI remains diffuse and clearly does not 
colocalise with Ad4 DBP (fig. 18B and 18D). Thus the redistribution of 
NFI in Ad2 infected cells is likely to be the result of a targeting event 
specific to this particular virus that reflects the requirement for NFI in 
Ad2 DNA replication.
FIGURE 18. NFI does not colocalise with DBP in Ad4 infected cells. DBP (A and 
C) and NFI (B and D) distribution in A549 cells infected for 12 hours (A and B) or 
18 hours (C and D) with Ad4.
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Nuclear distribution of NFI and Ad2 DBP in the absence of viral 
DNA replication
Although the results obtained above indicate that the nuclear 
redistribution of NFI that takes place after infection is specific to Ad2, it 
is not clear if this event precedes, or is a consequence of viral DNA 
replication. To provide an answer to this question A549 cells were 
infected with Ad2 at a high multiplicity of infection in the presence of 
lOmM hydroxyurea which inhibits viral and cellular DNA replication by 
depleting the intracellular pool of nucleotides. Double 
immunofluorescence analysis of untreated cells infected at the same 
multiplicity of infection revealed the expected colocalisation of NFI and 
DBP at a limited number of nuclear sites (fig. 19C and 19D). However 
analysis of infected cells in which DNA replication was blocked with 
hydroxyurea indicated that although the two proteins still appeared to 
colocalise the distribution of sites within the nucleus was different from 
that observed in untreated infected cells (fig. 19A and 19B). In 
hydroxyurea treated cells NFI and DBP were present in a large number 
of 'prereplicative sites', that although punctate in appearance were 
considerably smaller than the areas of fluorescence observed in 
untreated Ad2 infected cells (fig. 19; compare A and B with C and D). 
NFI and DBP therefore appear to colocalise in Ad2 infected cells even 
in the absence of viral DNA replication.
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FIGURE 19. A549 cells were infected at lOp.f.u./cell with Ad2 for 18 
hours in the presence (A and B) or absence (C and D) of lOmM 
hydroyurea to investigate whether the distribution of DBP (A and C) and 
bfrl (B and D) changé when DNA replication was inhibited.
SUPPLEMENT
Fate of NFI after Ad2 infection of AS49 cells
Figure 12 is a composite figure showing that the overall amount 
and DNA binding activity of NFI does not change throughout the course 
of infection.
A. demonstrates that the polyclonal antisera raised against 
N FIdbd (oc-NFI) immunoprecipitates (IP) NFI from an extract (Ex) of 
Spodoptera frugiperda cells infected with NFI expressing baculovirus 
(AcNPV NFI). This immunoprécipitation should have been duplicated 
using antisera obtained from the rabbit before it was immunised with 
NFI to show that the precipitating antibodies were the result of an 
immune response against NFI.
B. The first panel is a Western Blot which demonstrates that a -  
NFI antibody recognises denatured, full length and the DNA binding 
domain of NFI from extracts of Spodoptera frugiperda cells infected 
with recombinant baculovirus. Unfortunately the second track is hard 
to interpret because N F Ifl is prone to proteoytic attack resulting in 
only the DNA binding remaining intact. To clarify this it is advisable to 
leave empty wells between samples so that the charge of overspiU can be 
properly refuted. This figure should also have included a sample of 
uninfected cells or cells infected with an alternative recombinant 
baculovirus to demonstrate more clearly the specificity of the antisera.
D. is a gel retention assay demonstrating that the DNA binding 
activity of NFI does not vary as infection proceeds. The last three lanes 
are competition assays where IfiO-fold molar excess of competitor 
oligonucleotides containing the DNA binding sites of either NFI, NF-kB 
or NFni were also added. These demonstrate that the major protein- 
DNA complex formed is specific to NFI binding to its recognition site. 
This assay could also have been used to test the antisera by
preincubating the extracts with it before addition of the labelled 
oligonucleotide to see if the antibodies abolished the DNA binding 
activity of NFI or supershifted the protein-DNA complex.
89
CHAPTER THREE
Discrete subnuclear sites of transcription in Ad2 infected cells.
Since DBP and NFI colocalise at discrete sites of viral DNA 
replication perhaps other nuclear processes also occur at discrete 
subnuclear sites.
E la  does not colocalise with DBF in Ad2 infected cells
To investigate the relative distribution of DBP and the viral 
transcriptional activator E la in Ad2 infected cells antibodies to DBP and 
E la  were applied to the same cells and visualised by double 
fluorescence and laser-scanning confocal microscopy. Monoclonal 
antibodies directed against epitopes on E la were used in conjunction 
with a Texas Red conjugated donkey anti-mouse immunoglobulin 
whereas an FITC conjugated donkey anti-rabbit immunoglobulin was 
used to localise the rabbit antibodies bound to DBP. Figure 20A shows 
the usual punctate distribution of DBP in A549 cells infected at a high 
multiplicity of infection (50 p.f.u./ceU) for 18 hours as viewed by laser 
scanning confocal microscopy. Clearly although E la  (fig. 2GB) is 
distributed to discrete sites within the nuclei they are very distinct from 
those of DBP a fact that is highlighted when the two separate DBP and 
E la  images are coloured and merged (fig. 20C).
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FIGURE 20. Ela (B) does not colocalise with DBP (A) in A549 cells infected with 
Ad2 and examined by laser scanning confocal microscopy.
C. The image from A and B has been coloured and merged to demonstrate how they do not colocalise.
Synchronisation of cells at the Gl/S boundary of the cell cycle
A549 cells were grown to 80% confluence and then l|xg/ml 
aphidicolin was used to block DNA synthesis thereby synchronising the 
cells at the Gl/S boundary of the cell cycle. The aphidicolin block was 
removed after 18 hours and its effectiveness and the passage of the cells 
through the cell cycle was monitored using FACScan Flow Cytometry.
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Figure 21 illustrates the effectiveness of aphidicolin-mediated 
synchronisation of uninfected cells: two G 1  peaks occur 1 2  hours apart 
and S-phase occurs between 1 and 7 hours after tlie removal of 
aphidicolin peaking at 4 hours with 78% of the cells.
III
I
S-Dhase
0 5 10 15
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FIGURE 21, The passage of uninfected cells through the cell cycle after release 
from their aphidicolin-mediated synchronisation at the Gi/s-phase boundary.
Subsequent experiments involved studying the nuclear 
localisation of a number of proteins in A549 cells that were in G i, S- 
phase or G^M at the point of Ad2 infection. Tlie cells were infected at 
specific times after the aphidicolin block on DNA synthesis was 
removed: zero hours for G i, five hours for S-phase and eight hours for 
GzM.
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Effect of host cell cycle on DBP and E la  localisation
A549 cells were infected in G i, S-phase and G%M at a high 
multiplicity of infection (50 p.f.u./cell) for 12 hours. The distribution of 
DBP and E la was investigated by single fluorescence and conventional 
fluorescence microscopy. Monoclonal antibodies directed against DBP 
or E la  were used in conjunction with a Texas Red conjugated donkey 
anti-mouse immunonglobulin. Figures 22A, C, E show the pattern of 
DBP distribution in cells that were infected in G i, S-phase and G 2 M 
respectively. There are no striking differences in DBP distribution 
between cells infected in Gi (fig. 22A), S-phase (fig. 22C) and G2 M 
(fig. 22E). Conversely figures 22B, D, F show that E la  distribution is 
dependant on the cell cycle phase of the cells at the point of infection. 
Those infected in G i show a diffuse distribution of E la  throughout the 
nuclei (fig. 22B) whereas E la in cells infected in S-phase (fig. 22D) and 
G2 M (fig. 22F) is localised to discrete subnuclear sites that are not at aU 
reminiscent of DBP distribution.
FIGURE 22 (next page). A549 ceils were infected at 50p.f.u./cell for 12 hours in G% 
(A and B), S-phase (C and D) and G%M (E and F) and the distributions of DBP (A, C 
and E) and Ela (B, D and F) were examined using conventional fluorescence microscopy.
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E la  does not colocalise with RNA polymerase II in Ad2 infected 
cells
Since the primary role of the E la  proteins is to stimulate viral 
gene transcription it seemed reasonable that the discrete subnuclear sites 
of E la  distribution in Ad2 infected cells could be sites of viral 
transcription. All mRNA transcripts that code for proteins are 
synthesised by cellular RNA polymerase U so its distribution in Ad2 
infected cells was compared with that of E la to see if they colocalised. 
Monoclonal antibodies directed against E la  were used in conjunction 
with a Texas Red conjugated donkey anti-mouse immunoglobulin 
whereas an FITC conjugated donkey anti-rabbit immunoglobulin was 
used to localise the rabbit antibodies bound to RNA polymerase II. The 
distribution of these proteins was examined in cells whose cell cycle had 
been blocked at the Gi/S boundary with aphidicolin and then released so 
that the cells were in Gi (fig. 23A and B), S-phase (fig. 23C and D) and 
GiM  (fig. 23E and F). Once again it can be seen that the distribution of 
E la  is diffuse in Gi (fig. 23A) but finely punctate in S-phase (fig. 23C) 
and G%M (fig. 23E). RNA polymerase II is also found at discrete sites 
within the nuclei of cells infected with Ad2 during S-phase (fig. 23D) 
but these sites do not correspond with E la localisation, in fact RNA pol 
n  appears to be localised to the nucleoli (fig. 23 D). In cells infected in 
Gi or G 2 M there are some feint indications that RNA polymerase II is 
distributed to the nucleoli but on the whole it seems diffusely distributed 
throughout the nucleus. Control experiments in which one of the 
primary antibodies were omitted indicated that there was no crossover in 
the FITC (fig. 23G) and Texas Red (fig. 23H) channels.
FIGURE 23 (next page). E la (A, C and E) does not colocalise with RNA 
polymerase II (B, D and F) in cells that were infected in Gi (A and B), S-phase (C and D) or G2M (E and F).
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Visualisation of sites of transcription and replication in Ad2 infected 
cells
Ad2 infected cells (50 p.f.u./ceU for 12 hours) and uninfected cells 
were encapsulated, lysed with streptolysin O and incubated for 15min 
with Br-UTP and/or Biotin-16-dUTP. After permeabilising the nuclear 
membrane with Triton X-100 and fixation with paraformaldehyde sites 
of Br-UTP incorporation were indirectly labelled using an antibody that 
reacts with Br-RNA followed by a second antibody conjugated with 
Texas Red. Sites of Biotin-16-dUTP incorporation were directly 
labelled using Streptavidin-FITC.
hi uninfected cells most of the cells exhibit RNA polymerase n  
activity with the nuclei containing several hundred fluorescent foci 
spread throughout the extranucleolar regions (fig.24C). The nucleoli 
appear as dark 'holes' in DAPI stained cells (fig. 24B and D). In a 
minority of cells RNA polymerase I labelling is apparent with a number 
of fluorescent foci confined to the nucleoli (fig 24A).
hi Ad2 infected cells there is a general reduction in Br-UTP 
incorporation (fig. 24F and I). DAPI staining of these cells (fig. 24G 
and J) illustrates the general reorganising of the cellular DNA which is 
excluded from the sites of viral DNA replication and the breakdown of 
the nucleoli. Labelled transcription sites mainly seem to be concentrated 
outside the sites of viral DNA replication (fig. 24E and H) although 
further experiments are required to optimise the double labelling of 
replication and transcription sites.
FIGURE 24 (next page). Sites of transcription were visualised in uninfected (A and 
C) and Ad2 infected (F and I) A549 cells by conventional fluorescence microscopy. 
Uninfected (B and D) and Ad2 infected (G and J) cells were also stained with DAPI 
and sites of DNA replication were visualised in Ad2 infected cells (E and H).
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SUPPLEMENT
D iscrete subnuclear sites of transcrip tion  in Ad2 infected 
cells
Although E la  is the primary transactivator of early viral gene 
expression (Moran et al., 1986) it is unable to directly bind to DNA 
(Ferguson et al., 1985) and so operates by modifying the activity of 
cellular transcription factors. Therefore it would not be unreasonable 
for E la  not to localise to sites of transcription, A more appropriate 
candidate for studying the location of transcription sites is the 
transcription factor E2F which undergoes a dramatic change in activity 
during adenovirus infection (Kovesdi et al., 1986) which is mediated by 
E la. The 19kD gene product interacts with E2F enabling it to bind to 
the E2 promoter so that transcription can proceed (Huang and Hearing, 
1989; Bagchi et al., 1990; Raychaudhuri et al., 1990). E la's role in this 
is to interact with Rb thereby preventing it from interacting with E2F 
which would inhibit its ability to bind to the E2 promoter (Bagchi et ah, 
1991), Since E2F actually binds to the E2 promoter it is much more 
likely to colocalise with sites of transcription than E la. It would be 
interesting for further experiments to investigate whether E2F actually 
does localise to sites of transcription labelled with Br-UTP. Other 
future experiments could involve the use of inhibitors of transcription 
such as a-amanitin (which inhibits RNA pol II) to characterise the types 
of transcription being labelled using Br-UTP.
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DISCUSSION
Adenovirus types 2 and 5 require the viral proteins pTP, pol and 
DBP plus two cellular proteins NFI and NFIU for efficient initiation of 
DNA replication. These proteins form a nucleoprotem preinitiation 
complex at the origin of DNA replication which involves a number of 
direct protein-protein and protein-DNA interactions as well as some 
indirect cooperative interactions. The data presented in Chapter 1 
concerns the role of NFI in the formation of this nucleoprotein complex.
Ad2 initiation of DNA replication is affected by the relative 
concentrations of NFI and DBP. The initiation reaction is inhibited by 
DBP in the absence of NFI and stimulated in the presence of NFI 
(Nagata et al., 1982). The stimulation of replication by NFI is strongly 
dependant on the concentration of DBP (de Vries et al., 1985). DBP 
increases the affinity NFI has for its recognition site in the adenovirus 
origin of DNA replication (Cleat and Hay, 1989a; Stuiver and van der 
Vliet, 1990) in a specific reaction that cannot be substituted for by other 
single stranded DNA binding proteins such as E. colt SSB, HeLa SSB 
or T4 gene 32 protein (Cleat and Hay, 1989a). DBP increases the rate of 
NFI association with and decreases the rate of dissociation from its DNA 
recognition site (Cleat and Hay, 1989b) thereby resulting in increased 
binding of NFI. No direct interaction has been found between NFI and 
DBP so it seems most likely that DBP distorts the structure of the DNA 
so as to allow optimal base contacts between NFI and its recognition site 
thereby increasing its binding affinity (Stuiver et al., 1992).
Native NFI consists of a family of related proteins which range in 
size from 52 to 66kD (Jones et al., 1987) and are generated as a result of 
differential RNA splicing (Santoro et al., 1988). Functional domains 
were identified (Mermod et al., 1989; Meisteremst et al., 1989; Gounari
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et al., 1990) and found to consist of the N-terminal region which is 
required for DNA binding, dimérisation and stimulation of adenovirus 
DNA replication in vitro and the proline rich C-terminal region which is 
additionally required for transcriptional activation.
As expected the DNase I footprinting experiments in Chapter 1 
showed that NFIfl  and NFId b d  bind to the Ad2 origin of DNA 
replication with similar affinity and indistinguishable pattrems of DNase 
I protection. Futhermore they demonstrate that DBP can cooperate with 
the DNA-binding domain of NFI to increase its affinity for its 
recognition site which is reasonable since NFId b d  is sufficient to 
stimulate Ad2 initiation of DNA replication. Although it was known 
that initiation of adenovirus DNA replication is stimulated by the N- 
terminal region of NFI and that this stimulation is dependant on NFI 
binding to its recognition site (Leegwater et al., 1985) its role in 
adenovirus DNA replication was still not clear.
The NFI recognition site lies between base pairs 24 and 39/40 
(Leegwater et al., 1985) in the Ad2 and Ad5 origins of DNA replication. 
The terminal 18bp is referred to as the 'core' of the replication origin and 
is present in Ad4 as well as Ad2 and Ad5. Ad4 only needs this core 
region for efficient initiation of DNA replication (Hay, 1985) but in Ad2 
and Ad5 it can only support a limited level of DNA replication 
(Tamonoi and Stillman, 1983; Challberg and Rawlins, 1984). The 
spacer region between the core and the NFI recognition site was found 
to be essential with any insertions of DNA sequences reducing the level 
of initiation of DNA replication to that of the core only (Bosher et al., 
1990). This strict spatial arrangement of the NFI binding site with 
respect to the core region suggested the possibility that NFI mediated 
stimulation of DNA replication involves a direct or indirect interactipn 
with a replication component at the core. If the role of NFI in
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adenovirus replication involves a direct protein-protein interaction then 
if must be accomplished by the DNA binding domain since it carries out 
all the Adenovirus DNA replication functions of NFL The most likely 
candidate for a protein-protein interaction with NFI at the origin core 
was the DNA polymerase. Initiation of adenovirus DNA replication 
takes place when a covalent linkage between the a-phosphoryl group of 
the terminal nucleotide (dCMP) and the P-OH group of a serine residue 
in pTP is formed. Pol and pTP form a very tight heterodimer which 
requires glycerol gradient sedimentationin the presence of 1.7M urea to 
be broken (Lichy et ah, 1982). It seemed likely that the pol-pTP 
heterodimer would be positioned at the core region of the origin of 
replication and one or both proteins could interact with NFI. This was 
investigated using very small columns containing 50pl of NFId b d  
coupled to CNBr activated sepharose. Extracts of S. frugiperda cells 
that had been infected with recombinant baculoviruses expressing pTP, 
pol or a mixture of both were applied to the columns. It was shown that 
pol interacts with NFId b d  in isolation and as part of the pTP-pol 
heterodimer. So the proposed role for NFI in Ad2 DNA replication is to 
load the pol-pTP heterodimer onto the origin of DNA replication so that 
replication can be initiated. NFI binds to the DNA as a dimer making 
contacts with its symmetrical recognition site in two major grooves (de 
Vries et ah, 1987) which means that each dimer of NFI could potentially 
bind two molecules of the pTP-pol heterodimer. Unfortunately only one 
of these would be correctly positioned for initiation (fig. 25) which 
suggests that other interactions may exist to stabilise the pTP-pol 
heterodimer position at the terminus of the adenovirus genome. One 
possibility is that the pTP-pol heterodimer could specifically recognise 
DNA sequences in the core region thereby stabilising the preinitiation 
complex. Previously Kenny and Hurwitz (1988) demonstrated that
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FIGURE 25. A model for the interaction of viral and cellular proteins at the 
adenovirus type 2 origin of DNA replication.
nucleotides between positions 15 and 22 on the displaced strand are 
crucial for pTP-pol complex formation and that they increase the affinity 
of pTP-pol for the DNA. However this was suggesting that the origin 
DNA had to be unwound before the pTP-pol heterodimer could bind to 
it. It has since been demonstrated using gel electrophoresis DNA 
binding assays and DNase I footprinting that purified pol and pTP can
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specifically bind to the core region protecting base pairs 8 to 17 from 
DNase I cleavage (Temperley and Hay, 1992). This pTP-pol 
heterodimer binding site conesponds to the sequence in the core that is 
perfectly conserved in all human adenovimses sequenced to date 
(Tamonoi and Stillman, 1983; Challberg and Rawlins, 1984). Another 
possibility is that pTP makes direct contact with the genome linked TP 
and it has been found that template DNA attached to TP can support 
levels of DNA replication in vitro up to 20 fold higher than template in 
isolation (Tamonoi and Stillman, 1982; van Bergen et al., 1983; 
Challberg and Rawlins, 1984; Harris and Hay, 1988). Indeed it has been 
reported that TP-DNA is able to bind pTP-pol more efficiently than 
protein free DNA with there being no effect on NFI binding (Pronk and 
van der Vliet, manuscript in preparation; cited in Pronk et al., 1992). A 
third possibility is that the binding of NFHI to its recognition site simply 
blocks the interaction of the pTP-pol heterodimer to that side of the NFI 
dimer.
It is therefore possible to propose a sequence of events that lead 
to the formation of a preinitiation complex at the origin of DNA 
replication in Ad2 and Ad5 (fig. 26). DBP which is produced in large 
amounts, interacts nonspecificaUy with the adenovims genome thereby 
facilitating the binding of NFI (Cleat and Hay, 1989; Stuiver and van der 
Vliet, 1990). NFHI binds to its recognition site adjacent to NFI. The 
pol-pTP heterodimer interacts with NFI (Bosher et al., 1990; Chen et al., 
1990; Mul et al., 1990) via pol and is loaded onto the core region. This 
preinitiation complex is stabilised by additional interactions such as 
between genome TP and pTP and/or between pTP-pol and the core 
region DNA (Temperley and Hay, 1992). This nucleoprotein complex 
must then isomerise to unwind the origin region and expose the single 
stranded DNA that is the template for the initiation reaction. Ad4 does
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not require cellular proteins for efficient initiation of DNA replication. 
The loading of Ad4 pTP-pol heterodimer onto the origin may involve a 
more stable site specific interaction between pTP-pol and the core of the 
replication origin resulting in no need for cellular factors.
Ad2 ori
1-18 spacer NFI NFin
DBP
NFI
NFin
p  pTP/pol
helix opening 
initiation of DNA synthesis
FIGURE 26. A model for the formation of the preinitiation complex at the 
adenovirus type 2 origin of DNA replication.
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The location and function of nucleoprotein complexes in adenovirus 
type 2 infected cells
Nuclei contain numerous distinct compartments which are not 
membrane bound where processes such as DNA replication and 
transcription take place in uninfected ceUs and cells infected by a variety 
of viruses.. As discussed in the introduction immunofluorescence 
microscopy and electron microscopy have demonstrated that DBP, pol 
and pTP colocalise at presumed sites of adenovirus DNA replication 
(Sugawara e ta l ,  1977; Reich e ta l,  1983; Sasaguri etal., 1987; 
Voelkerding and Klessig, 1986; Murti et al., 1990).
Immunofluorescence microscopy has revealed that NFI is 
distributed evenly throughout the nuclei of human cells. However upon 
infection with Ad2 this distribution is dramatically altered with NFI 
being localised to discrete subnuclear sites which correspond to the 
location of DBP. The sites of viral DNA synthesis were labelled by 
incorporation of bromodeoxyuridine into synthesising DNA within Ad2 
infected A549 cells. It was found that NFI and DBP colocalise to these 
sites of active viral DNA synthesis. A convenient way of differentiating 
between labelled sites of viral and cellular DNA synthesis is provided 
for by the mechanism of adenovirus DNA replication. The monoclonal 
antibody used to visualise the incorporated BrdU requires that the DNA 
be rendered single stranded which normally involves treating the cells 
with Eco RI and exonuclease HI. However since adenovirus replicates 
by a strand displacement mechanism this is unnecessary and allows for 
the visualisation of viral replication sites only.
This redistribution of NFI to sites of viral DNA replication in 
Ad2 infected cells is thought to be a specific targeting event that reflects 
the requirement for NFI in Ad2 DNA replication, rather than a non­
specific aggregation of nuclear proteins brought about by infection. The
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most striking evidence to support this proposal is that infection of A549 
cells with Ad4 does not result in the relocalisation of NFI even though 
the Ad4 DBP is localised to discrete sites that are indistinguishable from 
those present in Ad2 infected cells. Ad4 does not contain an NFI 
binding site in its origin of DNA replication and the presence of an NFI 
binding site in vivo (Hay, 1985; van Bergen et al., 1983) or the addition 
of NFI to an in vitro replication assay, even when the template contains 
the cognate binding site (Harris and Hay, 1988; Temperley and Hay, 
1991) does not stimulate viral DNA replication.
How NFI is directed to these subnuclear sites is unknown but a 
number of possibilities exist. It may simply be a matter of NFI binding 
to its DNA recognition site which is stimulated and stabilised by a 
number of protein-protein and protein-DNA interactions (Cleat and Hay, 
1989a; Stuiver and van der Vliet, 1990; Bosher et al., 1990; Chen et al., 
1990; Mul et al., 1990) to form the nucleoprotein complex. On the other 
hand it could be more complicated. NFI contains a recognisable nuclear 
localisation signal within its DNA binding domain (Gounari et a/.,1990) 
which is presumably required to direct the protein into the nucleus 
however it seems unlikely that nuclear localisation sequences (Silver, 
1991; Dingwall, 1991) are also used for intranuclear targeting. NFI may 
have an intranuclear targeting sequence such as the one found in DNA 
methyltransferase (Leonhardt et al., 1992) that is exploited by Ad2 
during DNA replication. DNA MTase has a diffuse nuclear distribution 
throughout Gi and G% but during S-phase it is localised to the sites of 
DNA synthesis. The sequence required for this localisation has been 
defined as being towards the N-terminus of the protein between amino 
acids 207 to 455 which is separate from the nuclear localisation 
sequence at amino acids 72 to 92.
106
A number of DNA replicative proteins have been found to 
localise to sites of DNA synthesis during S-phase some of which have 
also been shown to interact with the nuclear matrix at these sites. 
Proliferating cell nuclear antigen (PCNA), a component of the DNA 
polymerase Ô haloenzyme, has several nuclear patterns during DNA 
synthesis which allow S-phase to be subdivided and is therefore often 
used as a marker to assess S-phase synchrony (Bravo and McDonald, 
1987; Celis and Cells, 1985; Cells et al., 1987). Polymerase a  has also 
been shown to localise to sites of DNA synthesis in S-phase cells 
(Nakamura et al., 1984) and has been found to bind tightly to granular 
stmctures in the nuclear matrix (Yamamoto et a l, 1984). Various 
experiments have provided evidence that the replication complex is 
attached to the nucleoskeleton via one or more of its components 
suggesting that replicating DNA is moved through it (Jackson and Cook, 
1986; Nakayasu and Berezney, 1989; Mills et al., 1989).
Herpes simplex virus (HSV) DNA replication also occurs in 
discrete subnuclear sites. The HSV DNA-binding protein, ICP8, is 
localised to very small, evenly distributed discrete foci prior to DNA 
replication (prereplicative sites) and to larger, globular foci during DNA 
replication (replication compartments, Quinlan et al., 1984). ICP8 in 
prereplicative sites appears to be associated with the nuclear matrix 
since it is not extracted along with 99% of the cellular DNA, ICP8 in 
replication compartments on the other hand is extracted along with most 
of the cellular and HSV DNA which suggests that ICP8 dissociates from 
the nucleoskeleton for DNA replication to proceed (Quinlan et al.,
1984). In cells infected with HSV in the presence of phosphonoacetate 
(PAA, a specific inhibitor of HSV DNA polymerase) cellular DNA 
replication sites are found to localise to HSV prereplicative sites leading 
to the suggestion that cellular DNA replication complexes formed prior
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to infection are incorporated into the viral prereplicative sites (de Bruyn 
Kops and Knipe, 1988). The HSV DNA polymerase is normally found 
in preplicative sites and replication compartments except when cells are 
infected with mutant viruses encoding defective ICP8 when the 
polymerase is diffusely distributed throughout the nucleus. In cells 
infected with mutant viruses encoding defective polymerase ICP8 is still 
localised to prereplicative sites indicating that ICP8 is involved in the 
assembly of prereplicative sites (Bush et al., 1991). DNA synthesis 
inhibited in adenovirus infected cells by hydroxyurea results in a 
redistribution of both NFI and DBP to a very large number of very small 
discrete sites evenly distributed throughout the nucleus reminiscent of 
HSV prereplicative sites.
Although there is a body of evidence to support the proposal 
that cellular DNA replication occurs at fixed replication centres the same 
cannot be said for adenovirus and HSV DNA replication. However in 
SV40 Wessel et al. (1992) found that when bidirectional DNA 
unwinding is initiated at the viral origin of replication two T-antigen 
helicase hexamer complexes form a dodecamer complex at the 
replication fork through which the DNA is threaded producing single 
stranded loops rather than each hexamer complex moving along the 
DNA in opposite directions. This supports the model of SV40 DNA 
replication where DNA is threaded through a fixed replication center.
E la, a viral transcriptional activator, and DBP were found to be 
distributed to different discrete sites within the nuclei of Ad2 infected 
cells. Futhermore the distribution of DBP is not dependant on the stage 
of the cell cycle that the cells are in when they are infected whereas E la  
distribution is. Those infected in Gi have a diffuse E la  distribution 
whereas those infected in S-phase and G2 M have a fine, punctate E la 
distribution. White et al. (1988) distinguished five E la  patterns which
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correlate with the time post infection. At 6-12 hours E la staining was 
absent or diffuse; at 12-24 hours it was reticular, nucleolar or punctate 
and at 24-48 hours it was peripheral ar absent. For this thesis the cells 
were infected with 50p.f.u./cell for 12 hours because that gave the 
brightest E la  fluorescence. E la is known to bind to the retinoblastoma 
gene product (Rb, Whyte et al., 1988) which is diffusely distributed in 
Ad2 infected cells (Wilcock, 1991). Possibly E la is bound to Rb in cells 
showing diffuse E la distribution such as those in Gi. Since one of the 
goals of viral early protein expression is to push the cells into S-phase 
perhaps E la binding to Rb helps achieve this by blocking the normal 
function of Rb of constraining growth.
In an effort to assign the E la  punctate pattern a functional 
signficance its distribution was compared to that of RNA polymerase II 
which transcribes all protein encoding mRNÀs. However these proteins 
were shown not to colocalise in cells infected with 50p.f.u./ceU for 12 
hours. RNA pol II appears to be targeted to the nucleoli of the cells in 
S-phase whereas its distribution in Gi and G2 M seems much more 
diffuse. In order to ascertain whether either or none of these patterns 
correspond to adenovims transcription attempts were made to label sites 
of ongoing transcription. This was achieved by incubating encapsulated 
and permeabilised A549 cells with Br-UTP in a 'physiological buffer' 
followed by indirect labelling of nascent Br-RNA. RNA polymerases I 
and n  are responsible for most nucleolar and extra-nucleolar cellular 
transcription respectively. Labelling sites of transcription in uninfected 
cells showed that RNA pol I transcription occurs at a number of discrete 
sites within the nucleoli and that RNA pol II transcription occurs at 
several hundred discrete subnuclear sites which are reminiscent of the 
pattern of replication sites in early S-phase cells. However later on in S- 
phase the two distribution patterns are very different (P.R. Cook,
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personal communication). In the Ad2 infected cells the discrete sites of 
transcription seem to be clustered outside of the labelled sites of viral 
replication although further experiments are required to better define 
this. Adenovirus infection has a great affect on cellular processes 
resulting in the nucleoli being degraded (Phillips and Raskas, 1972) and 
rRNA synthesis being inhibited (Castiglia and Hint, 1983). Also host 
chromatin is excluded from sites of viral DNA replication to the margins 
of the nucleus (Puvion-Dutilleul and Puvion, 1991). From the results 
here it appears that transcription in adenovims infected cells is occuring 
at different sites to Ad2 DNA replication.
Further experiments would involve optimising the simultaneous 
labelling conditions of transcription and replication sites as well as the 
use of inhibitors such as a-amanitin (which inhibits RNA pol II) to 
characterise the types of transcription being labelled. Also the 
localisation of transcription factors such as E2F could be investigated 
since E2F is known to bind to the E2 promotor along with the 19kD E4 
gene product to stimulate transcription.
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